STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF CHAPERONES IN FE-S CLUSTER BIOGENESIS AND REGULATION by Puglisi, Rita
This electronic thesis or dissertation has been 











The copyright of this thesis rests with the author and no quotation from it or information derived from it 
may be published without proper acknowledgement. 
 
Take down policy 
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing 
details, and we will remove access to the work immediately and investigate your claim. 
END USER LICENCE AGREEMENT                                                                         
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 
International licence. https://creativecommons.org/licenses/by-nc-nd/4.0/ 
You are free to: 
 Share: to copy, distribute and transmit the work  
 
Under the following conditions: 
 Attribution: You must attribute the work in the manner specified by the author (but not in any 
way that suggests that they endorse you or your use of the work).  
 Non Commercial: You may not use this work for commercial purposes. 
 No Derivative Works - You may not alter, transform, or build upon this work. 
 
Any of these conditions can be waived if you receive permission from the author. Your fair dealings and 








STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF CHAPERONES IN FE-S




Download date: 15. Dec. 2017
	  	  	  	  	  	  	  
STRUCTURAL AND FUNCTIONAL 
CHARACTERIZATION OF CHAPERONES IN FE-S 




Doctor of Philosophy 
2017 	  
	   2	  
 
“Human beings would not even begin to search for something of which they knew 
nothing or for something which they thought was wholly beyond them. Only the 
sense that they can arrive at an answer leads them to take the first step. This is 
what normally happens in scientific research. When scientists, following their 
intuition, set out in search of the logical and verifiable explanation of a phenomenon, 
they are confident from the first that they will find an answer, and they do not give up 
in the face of setbacks. They do not judge their original intuition useless simply 
because they have not reached their goal; rightly enough they will say that they 
have not yet found a satisfactory answer. The same must be equally true of the 
search for truth when it comes to the ultimate questions. 
The search for truth, even when it concerns a finite reality of the world or of man, is 
never-ending, but always points beyond to something higher than the immediate 
object of study, to the questions which give access to Mystery” (JP II, Fides et Ratio) 
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ABSTRACT 
Dysfunctions in Fe-S protein biogenesis and mitochondrial iron accumulation in 
heart and neurones are part of the phenotype of a genetic neurodegenerative 
disease called Friedreich's ataxia. This pathology is caused by the deficiency of a 
mitochondrial protein, frataxin, highly conserved throughout species and currently 
thought to be a regulator of Fe-S cluster biosynthesis. The study of the mechanism 
of Fe-S cluster assembly in mitochondria is important to provide insights and 
valuable information potentially relevant for the study of iron-storage diseases. The 
biogenesis of iron sulfur clusters involves a complex molecular machine with 
macromolecular structures containing multiple subunits with specific functions. The 
high level of conservation of the components suggests the bacterial system as 
excellent model because of its inherent lower complexity. Isc is one of the operons 
that encodes proteins responsible for Fe-S cluster biogenesis in bacteria, including 
the desulfurase IscS, the scaffold protein IscU on which the Fe-S cluster is 
assembled, the two chaperones HscA and HscB, the trascription regulator IscR, a 
ferredoxin and two other proteins called IscA and YfhJ, whose role is still unclear. 
The function of the chaperones HscA and HscB is thought to assist the transfer of 
the cluster from the scaffold protein to the final acceptors. 
The main objective of this project was to get new evidence to understand the 
functions of the chaperones and the mechanisms by which they are involved in Fe-S 
cluster biogenesis and regulation through the application of structural biology and 
biochemistry. In particular, I focused on the structural and functional characterization 
of co-chaperone HscB and the analysis of its interactions with other members of the 
machinery through NMR and other biophysical techniques. My main findings are 
that HscB has an unprecedently reported interaction with IscS and that this 
interaction slows down cluster formation explaining a large plethora of evidence. 
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These findings provide an entirely new perspective to the comprehension of the role 
of HscB and propose this protein as partner of central components of the Isc 
machine. 
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INTRODUCTION 
Iron is an essential element for life. The survival of prokaryotic and eukaryotic 
organisms depends on it and both the lack and an excess of free iron lead the cell to 
death. Free iron is toxic and at the same time a deficiency of iron is deleterious to 
cells because it is required as a constituent of functional groups. (Hentze, 
Muckenthaler et al. 2004). A tight regulation of iron metabolism is thus demanded. 
Determining its homeostasis and how its cellular forms are regulated in amount and 
allocation is of particular importance for understanding how these mechanisms can 
be at time so compromised to cause pathological conditions, such as metabolic and 
neurodegenerative diseases. 
Important prosthetic groups containing iron are Fe-S clusters which are present both 
in prokaryotes and eukaryotes. They are formed under the control of complex 
machineries highly conserved through species (Cowan 2009). These machines 
were discovered several years ago and little is still known about how the Fe-S 
cluster biosynthesis works and how its malfunctioning is related to disease. 
In bacteria, the genes responsible for cluster biogenesis are mostly grouped in three 
distinct operons (named nif, suf and isc) (Jacobson, Cash et al. 1989, Lill and Kispal 
2000, Py, Moreau et al. 2011). The isc operon contains genes encoding for eight 
proteins each of them with a close orthologue in eukaryotes (Tokumoto and 
Takahashi 2001). These proteins include a desulfurase, IscS, which is able to 
convert cysteine into alanine and liberate sulfur, a scaffold protein, IscU, on which 
the cluster is assembled, the two chaperones HscA and HscB, though to assist the 
trasfer of the cluster to an apo-acceptor, a ferredoxin and three other proteins for 
which little is known. Even if some reports attempeted to provide information on the 
role of specific components, a clear picture of how the whole machine works is still 
missing.  
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The study of the simpler bacterial model system may help to understand also how 
iron is correlated to human diseases. Some imbalance or damage of the Isc 
components in human may cause serious neurodegenerative diseases such as the 
hereditary Friedreich’s ataxia (Puccio and Koenig 2000). This pathology is caused 
by the deficiency of a mitochondrial protein, frataxin, extremely conserved 
throughout species. It takes part in the Fe-S cluster machinery and currently it is 
thought to act as a regulator of the enzymatic activity of the desulfurase IscS even 
though, in bacteria, it is not encoded by the isc operon (Pandolfo and Pastore 2009). 
An intriguing issue is that of better understanding the mechanism of Fe-S cluster 
biosynthesis. Adding a new tessera to this complicated puzzle was the main 
purpose of my PhD project.  
I first dissected the machinery by investigating on the simpler bacterial system with 
a biochemical approach. I studied the kinetic of cluster assembly in vitro in the 
presence of the desulfurase IscS and scaffold IscU and observing the effect that 
chaperones HscA and HscB have on it. 
However, the comprehension of the mechanism of Fe-S cluster formation could be 
achieved only with the structurally and functionally characterization of the 
components of the machinery and the study of their mutual interactions. I started by 
exploring the role of the co-chaperone HscB. With the help of several different 
biochemical assays and biophysical techniques (as pull-down assays, size 
exclusion chromatography, crosslinking, NMR relaxation measurements, ITC and 
MST) I documented a previously undetected weak interaction between the 
chaperone HscB and the desulfurase IscS, one of the two main players of the 
machine. The surfaces of interaction were then obtained using HSQC and cross 
saturation NMR experiments and validated with the mutagenesis of residues 
involved. 
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In my thesis, I present the work I carried out during my PhD course at King’s 
College London. It is divided in chapters which describe biochemical, biophysical 
and structural approaches depending on the studies performed.  
During my studies, I had the possibility to use several different techniques and to 
learn about their employability in the investigation of molecular basis of 
neurodegenerative diseases (Prischi and Pastore 2016). For each of them I explain 
the main principles and characteristics in boxes.  
In the conclusive chapter I show the reasons why the existence of a complex 
between HscB and IscS adds a completely new perspective to the comprehension 
of the Isc machinery and HscB can be supposed to be one of the main players in 
the mechanism of Fe-S clusters formation. 
All these finding have also been described in a paper published in Frontiers in 
Molecualar Biosciences in September 2016 (Puglisi, Yan et al. 2016). 
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1. IRON-SULFUR CLUSTERS 
Iron is ubiquitous in the environment and in biology. Eukaryotic cells (and most 
prokaryotic organisms) require iron for survival and proliferation, as a constituent of 
hemoproteins, iron-sulfur (Fe-S) proteins and other proteins that use iron in 
functional groups to carry out essential housekeeping functions for cellular 
metabolism. Cellular iron deficiency arrests cell growth and leads to cell death 
(Hentze, Muckenthaler et al. 2004). 
The biological importance of iron is largely attributable to its chemical properties: it is 
involved in one-electron oxidation-reduction reactions with transition between its 
ferric and ferrous states. However, the same chemical property explains why an 
excess of free and reactive iron is toxic. In the cytoplasm, a significant fraction of 
iron is reduced and can participate in “Fenton-type” redox chemistry. Ferrous iron 
reacts with hydrogen peroxide (H2O2) or lipid peroxides to generate ferric iron, OH-, 
and the highly reactive hydroxyl radical (HO•) or lipid radicals such as LO• and 
LOO•. Ferric ion is then reduced back to Fe2+ by another molecule of hydrogen 
peroxide, forming a hydroperoxyl radical (HOO•) and proton. Iron behaves thus as a 
catalyst, meaning that very low quantities of free iron can be toxic. Radicals 
produced damage lipid membranes, proteins, and nucleic acids (Hentze, 
Muckenthaler et al. 2004, Jang and Imlay 2010).  
 
€ 
Fe3+ +H2O2 →Fe2+ +HOO⋅ +H +  
Since both cellular iron overload and iron deficiency cause cell death, the levels of 
reactive iron must be carefully controlled and limited (Hentze, Muckenthaler et al. 
2004). 
Biological iron–sulfur (Fe-S) clusters were identified about 50 years ago as acid-
labile prosthetic groups contained within a class of electron carrier proteins called 
ferredoxins (Frazzon and Dean 2003). They are widely distributed in nature and can 
€ 
Fe2+ +H2O2 →Fe3+ +OH − +HO⋅
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be found in anaerobic, aerobic and photosynthetic bacteria, fungi, plants and 
mammals (Cowan 2009). Most known Fe-S proteins of a eukaryotic cell are located 
in the mitochondria, but some also exist outside of them. Finally, at least one Fe-S 
protein, the endonuclease Ntg2p, has been localized to the cell nucleus (Lill and 
Kispal 2000). 
Since their discovery, Fe-S clusters have been considered ideal agents of electron 
transfer because of their versatile electronic properties (Beinert, Holm et al. 1997). 
Many different proteins that contain these clusters have been described with 
different functionality (Johnson 1998). 
Fe-S clusters are now known to have roles in controlling protein structure and in 
enzyme active sites (see for instance aconitase), to act as environmental sensors 
(as in FNR), to serve as modulators of gene regulation (IRP and SoxR), and to 
participate in radical generation (Beinert, Holm et al. 1997). Such functional diversity 
almost reflects the chemical versatility of iron and sulfur, leading to the suggestion 
that prebiotic iron-sulfur complexes could have played an important role in the 
emergence of life on earth. The importance of Fe-S clusters is furthermore 
underlined by their involvement in three major processes required to sustain life on 
earth: nitrogen fixation, photosynthesis and respiration (Frazzon and Dean 2003). 
 
1.1 Structure and function 
The most common Fe-S clusters found in nature are [2Fe–2S] and [4Fe–4S] 
clusters and these are usually coordinated to proteins by cysteine ligands. However, 
biological Fe-S clusters of higher nuclearity have been discovered, and not all are 
attached to their protein partners through cysteines. Despite the apparent diversity 
in the overall structure, reactivity, electronic properties and polypeptide 
environments, polynuclear Fe-S clusters are all constructed from [2Fe–2S] rhombs 
(Frazzon and Dean 2003). For example two [2Fe-2S] units may be converted to the 
cubane [4Fe-4S]. Cuboidal cluster [3Fe-4S] is considerably less stable. It has been 
assembled from [4Fe-4S] via loss of one iron atom and it could be converted to 
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linear [2Fe-2S] or cubane [4Fe-4S] (Beinert, Holm et al. 1997). In addition, not all 
Fe-S proteins contain clusters with Fe as the only metal: the nitrogenase MoFe 




Figure 1.1 Various [Fe-S] clusters found in iron–sulfur proteins. The most common (a) [2Fe–2S] 
and (b) [4Fe–4S] clusters are coordinated to their protein partners by cysteine ligands. Iron–sulfur 
clusters of higher nuclearity such as (c) the [8Fe–7S] cluster and (d) the [Mo–7Fe–9S] FeMo-cofactor 
from nitrogenase represent just some of the intricate possibilities of more complex biological iron–sulfur 
clusters. (Iron is represented in green, sulfur in yellow and molybdenum in magenta) (Frazzon and 
Dean 2003). 	  
Because of their structural and chemical versatility, Fe-S clusters present an 
extreme functional flexibility. The electronic structures of Fe-S clusters have been 
studied by a variety of spectroscopic techniques (Glaser, Hedman et al. 2000) 
showing that they are ideal agents for electron storage and transfer, signaling and 
regulation, via their tunable sensitivity to various oxidants or reductants. Fe-S 
favourable conditions and appropriate organization of the
necessary ligands, certain biologically releva t [Fe–S]
clusters have the capacity to form spontaneously. Never-
theless, spontaneous, intracellular assembly of [Fe–S]
clusters using free Fe2þ/3þ and S2" is not an attractive
physiological prospect because these elements are meta-
bolic poisons, especially in the concentrations and under
the conditions required to achieve chemical [Fe–S]
cluster assembly. A more reasonable expectation was
that [Fe–S] clusters are formed biologically by protein-
directed activation a d specific delivery of Fe and S to
the assembly site, and this possibility turned out to be
correct. Here we discuss the origins of the identification
of proteins involved in [Fe–S] cluster assembly in bac-
teria and our current understanding of the functions of
those proteins.
Origins of the concept of molecular scaffolds
for complex metallocluster assembly
Observations leading to the discovery of proteins
involved in [Fe–S] cluster assembly did not initially come
from an analysis of the formation of simple [2Fe–2S] or
[4Fe–4S] clusters, but rather emerged from attempts to
understand the assembly of one of nature’s most complex
[Fe–S] clusters, the FeMo-cofactor of the nitrogenase
MoFe protein. FeMo-cofactor (Figure 1d) has attracted
the attention of the bioinorganic community for many
year because it provid s the site fo biological nitrogen
reduction. Genetic and biochemical studies established
that a consortium of proteins is required to assemble
FeMo-cofactor. Two general pathways for this process
were initially considered. Namely, FeMo-cofactor could
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clusters are well suited to supply single electrons, as required in homolytic reactions 
(Beinert and Kiley 1999), but they can also act as sensors of molecules in their 
immediate environment (Jervis, Crack et al. 2009). Fe-S clusters are sensitive to 
cellular oxidants and in vitro they may also respond to strong reducing agents or 
ligands for iron that are stronger than their sulfur ligands. Oxidation of Fe-S clusters 
may cause cluster rearrangement or total disassembly (Crack, Green et al. 2012).  
A first example is fumarate and nitrate reductase FNR, an E. coli regulator 
controlling the synthesis of proteins required for anaerobic respiration with nitrate, 
fumarate, trimethylamine oxide and similar electron acceptors replacing oxygen. 
FNR is functional only in its dimeric form, stabilized by [4Fe-4S] cluster. Binding 
DNA with high affinity, it controls gene expression. The [4Fe-4S] cluster is very 
sensitive to oxygen, which rapidly converts it to the more air-stable [2Fe-2S] form 
making FNR inactive and monomeric (Johnson 1998, Beinert and Kiley 1999, 
Zhang, Crack et al. 2012). 
Another example is SoxR that contains [2Fe-2S] cluster and is activated on 
exposure of cells specifically to superoxide O2- and NO, but not to H2O2 or HO!. In 
enteric bacteria active SoxR activates transcription of only a single gene, soxs, 
leading to the formation of the SoxS protein which regulates expression of a number 
of genes whose products function in the defense against O2- and NO (Beinert and 
Kiley 1999). 
Fe-S clusters can serve also as active sites of enzymes as, for instance, in 
mitochondrial aconitase involved in the tricarboxylic acid cycle and able to convert 
citrate to isocitrate (Beinert, Kennedy et al. 1996). A [4Fe-4S] cluster is bound to the 
enzyme through cysteine groups. Three iron are involved in the binding and the 
fourth serves as a Lewis acid in catalyzing the transformation of the substrate 
(Beinert 2000). The cluster destruction, due for example to deleterious free radicals, 
or (re)synthesis will determine the activity of aconitase and hence control the citric 
acid cycle (Beinert and Kiley 1999). Cytosolic aconitase, a close relative of the 
mithochondrial enzyme, can switch to the IRP1 form by loosing the Fe-S cluster 
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binding. In iron-deficient cells, the Fe-S devoid form (IRP1) regulates the expression 
of iron metabolism genes by the binding to iron-responsive elements (IRE), specific 
mRNA targets found in the mRNAs of ferritin, the transferritin receptor and other iron 
metabolism transcripts. (Rouault 2006). 
 
1.2 Systems of Fe-S cluster biosynthesis 
Fe-S clusters can be spontaneously assembled in vitro from the required 
components and under the proper conditions: the presence of iron and a source of 
sulfur such as lithium sulfide (Bonomi, Iametti et al. 2005). However, in both 
prokaryotes and in eukaryotes, enzymes have been identified that use pyridoxal 
phosphate for desulfurase activity, transforming cysteine into alanine and elemental 
sulfur. Similarly, specific carrier-proteins for Fe are likely to be used. Thus, the 
formation of clusters is driven by the availability of iron and four cysteines: one to 
provide sulfur for the synthesis and three others to stabilize the Fe-S cluster 
created. When only two cysteines are available per peptide, the peptide will 
dimerize to make a [4Fe-4S] cluster (Beinert 2000). 
Investigation on Fe-S cluster maturation in bacteria has led to the identification of 
two operons termed nif (nitrogen fixation) and isc (iron–sulfur cluster assembly). The 
nif operon encodes proteins that execute specific functions in the assembly of 
nitrogenase, a complex metalloenzyme that catalyses the fixation of nitrogen. The 
isc operon encodes proteins necessary for the maturation of bacterial Fe-S proteins. 
Many of the gene products encoded by the nif and isc operons have sequence 
similarity to the eukaryotic components of Fe-S protein maturation (Lill and Kispal 
2000). 
In addition to the Isc, in E. coli it was identified another system responsible for the 
Fe-S cluster biosynthesis: Suf. Although Isc and Suf are systems that rely on to the 
same activities (i.e a cysteine desulfurase, a scaffold protein, an ATPase and a Fe-
S acceptor protein), genetic and biochemical characterizations revealed differences 
in their ability to function under stress conditions (Tokumoto, Kitamura et al. 2004). 
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In fact they are considered the house-keeping and stress-dedicated systems, 
respectively. Both operons are co-regulated by the same transcriptor factor, IscR, 
able to bind the cluster. Apo-IscR activates the expression of the suf genes whereas 
the holo-form represses the expression of the isc operon. It was also pointed out 
that the Isc system is inactivated by reactive oxygen species (ROS) since a solvent-
exposed Fe-S cluster, built on the scaffold IscU, can be easily oxidized by ROS. On 
the other hand, Suf might have evolved to be efficient when Fe and S are present in 
limited amount. As a result of that, Isc is the primary system used in exponentially 
growing cells, whereas Suf is used under oxidative stress and iron starvation 
conditions (Outten, Djaman et al. 2004, Py, Moreau et al. 2011). 
In eukaryotes an Isu system has been discovered in mitochondria and it is able to 
mediate the Fe-S cluster assembly and to transfer it to apo-acceptors. Isu and Isc 
proteins are very similar in sequence and function (Cowan 2009). A parallel 
cytoplasmic Fe-S cluster machinery, CIA, is responsible for the maturation of Fe-S 
proteins autside mitochondria (Stehling and Lill 2013). 
 
1.3 Isc system 
Understanding the functions of Isc proteins in prokaryotes is important to provide 
insights into Fe-S cluster assembly in mitochondria, with potential relevance in iron-
storage diseases and the control of cellular iron uptake. 
The isc operon in the bacterium E. coli encodes eight proteins: IscR, IscS, IscU, 
IscA, HscB, HscA, Fdx and YfhJ (Tokumoto and Takahashi 2001). 
 
 
Figure 1.2 The isc operon. In E. coli the Isc operon encodes the proteins involved in the Fe-S cluster 
biogenesis. 
 
To elucidate their function, a systematic mutational analysis of the genes has been 
ŝƐĐZ ŝƐĐ^ ŝƐĐh ŝƐĐ ŚƐĐ ŚƐĐ ĨĚy ǇĬ:
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undertaken by Tokumoto et al. Mutants with inactivated iscR or orf3 showed no 
differences from wild-type cells while inactivation of the iscS gene elicited the most 
drastic alteration. Strains with mutations in the iscU, hscB, hscA, and fdx genes 
exhibited conspicuous phenotypical consequences almost identical to one another. 
The effect of the inactivation of iscA was small but appreciable on Fe-S enzymes 
(Tokumoto and Takahashi 2001). Tokumoto et al. also demonstrated a network of 
protein-protein interactions among Isc proteins. They speculated that the Fe-S 
cluster assembly works with a sequential association and dissociation among them. 
Combinations of IscS and IscU, IscU and HscB, IscU and HscA and HscB and HscA 
were observed as well as interaction between IscS and FdX, IscS and IscR, IscA 
and HscA and HscA and FdX (Tokumoto, Nomura et al. 2002). IscS accommodates 
the binding of at least two more proteins involved in the Fe-S cluster biosynthesis: 
the Isc-belonging YfhJ (Pastore, Adinolfi et al. 2006) and frataxin CyaY (Adinolfi, 
Iannuzzi et al. 2009). Figure 1.3 shows all the interactions currently evidenced 
between the Isc components. 
 
 
Figure 1.3 Isc Interactome. Isc proteins map a complex network of interactions. Each arrow 
evidences a proved direct molecular binding between two proteins. 
 
1.3.1 IscR 
IscR contains a [2Fe-2S] cluster and has a function as a regulator. Schwartz et al. 
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originates from a single promoter upstream of iscR that is repressed by IscR itself 
(Schwartz, Giel et al. 2001). When Fe-S cluster assembly becomes rate limiting, 
levels of [2Fe-2S]-IscR decrease as a result of a diminution in its rate of synthesis, 
and repression of iscRSUA is relieved. The resulting increase in the Isc assembly 
proteins subsequently leads to an increase in the rate of Fe-S cluster formation, 
causing levels of [2Fe-2S]-IscR to rise, thus resetting repression of the isc operon 
(Schwartz, Giel et al. 2001). 
The Isc proteins are able to distinguish between IscR and other apo-protein targets 
and IscR acquires a Fe-S cluster once the cellular demand for Fe-S cluster 
biogenesis is satisfied. IscR could be differentiated from other apo-proteins because 
the cluster is bound with an atypical ligation scheme of three cysteines and one 
histidine (Cys)3(His)1. The atypical amino acid ligand could make IscR a poor 
substrate for the Isc proteins and thus able to sense the cellular demand for Fe-S 
cluster biogenesis (Fleischhacker, Stubna et al. 2012). Giel et al. reported that the 
isc operon was more repressed under anaerobic conditions rather than under 
aerobic conditions (Giel, Nesbit et al. 2013). Fe-S clusters are sensitive to O2 (Imlay 
2006) so it is likely that Fe-S clusters are continuously damaged or destroyed during 
aerobic growth. As a result, levels of substrate proteins that need Fe-S biogenesis 
or repair increase. The higher rate of cluster turnover in aerobic condition leads to 
decrease isc repression. It suggests that there may be more competition between 
IscR and substrate proteins for the Isc machinery when O2 is present. In contrast, 
under anaerobic conditions, the Isc machinery appears to satisfy the Fe-S demand 
more efficiently, thus less competition among substrate proteins is observed and an 
increased repression of isc is due to increased of [2Fe–2S]-IscR (Giel, Nesbit et al. 
2013). 
These mechanisms would provide a global regulation to ensure that Fe-S clusters 
are synthesized when there is an increased demand. 
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1.3.2 IscS 
IscS is an extremely conserved protein that forms an obligatory dimer composed of 
two identical 45 kDa subunits. It is a pyridoxal phosphate (PLP) binding enzyme and 
it catalyzes the desulfurization of L-cysteine to yield L-alanine and generates a 
sulfur atom that is subsequently transferred to IscU (Urbina, Silberg et al. 2001) or 
other protein, for example ThiS, which plays an essential role with ThiI in the 
synthesis of thiamine (Kambampati and Lauhon 2000, Lauhon and Kambampati 
2000). In addition to the covalently bound PLP group, the active site of IscS contains 
a catalytic cysteine (Cys328) hosted in a flexible and conserved loop (residues 323-
335) and a conserved lysine (Lys206). During catalytic activity, the loop is thought to 
move from the active site to the scaffold protein to deliver the persulfide (di Maio, 
Chandramouli et al. 2017). Similarly to what was suggested for NIFS (the A. 
vinelandii homologue) mechanism, IscS catalyzes the formation of an external 
aldimine Shiff base between the amino group of the substrate and PLP. The 
cysteinyl thiolate anion of Cys328 generated in the active site makes a nucleophilic 
attack on the sulfur of the cysteine-PLP adduct and finally the cysteine persulfide 
and an enamine derivative of alanine are formed (Zheng, White et al. 1994, Fujii, 
Maeda et al. 2000). 
 
Figure 1.4 Proposed mechanism of desulfuration reaction. 
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Increasing evidences revealed an important role of IscS in several biological 
pathways such as the biosyntheses of Fe-S clusters, thiamine, thionucleosides in 
tRNA, biotin, lipoic acid, molybdopterin, and NAD. The enzyme is also proposed to 
be involved in cellular iron homeostasis and in the biosynthesis of selenoproteins 
(Mihara and Esaki 2002). 
 
 
Figure 1.5 Network of protein-protein interactions involving IscS. IscS initiates intracellular sulfur 
trafficking, delivering the sulfur to several sulfur-accepting proteins such as IscU, ThiI, TusA, and 
MoaD/MoeB that commit the sulfur to different metabolic pathways. IscU is the primary scaffold for 
assembly of Fe-S clusters. Frataxin/CyaY has been postulated as a Fe chaperone, a Fe donor for Fe-S 
cluster assembly, or a regulator of Fe-S cluster formation (Shi, Proteau et al. 2010). 
 
1.3.3 IscU 
IscU has been widely conserved throughout evolution and is considered to be one 
of the most conserved protein sequences in nature (Hwang, Dempsey et al. 1996). 
It contains three conserved cysteine residues (Cys37, Cys63, and Cys106) (Zheng, 
Cash et al. 1998), a conserved histidine residue (His205) and a conserved ‘LPPVK’ 
motif (Johnson, Dean et al. 2005, Shimomura, Kamikubo et al. 2007) and it has the 
ability to accommodate both [2Fe-2S] and [4Fe-4S] clusters (Agar, Krebs et al. 
2000). 
IscU is the scaffold protein on which Fe-S cluster are assembled and sustained until 
F -S cluster formation [14]. The network of k own IscS protein
interactions is shown in Figure 1.
Thiolated nucleotides are found in several tRNAs. In E. coli and
Salmonella enterica serovar Typhimurium, these are s4U8, s2C32,
ms2i(o)6A37, and (c)mnm5s2U34, which, with the exception of s4U8,
are located within the anticodon loop and are crucial for proper
mRNA decoding [21]. The base thiolations are mediated by several
acceptor proteins, falling into two distinct pathways [21]. In the
iron-sulfur cluster independent pathway, direct transfer of sulfur
from IscS to the acceptor ThiI leads to the s4U8 modification [22],
while transfer to TusA results in the (c)mnm5s2U34 modification
[23]. ThiI also participates in thiamine biosynthesis [24]. The
second pathway proceeds through the formation of an iron-sulfur
cluster and is dependent on the IscU acceptor protein. The enzymes
TtcA and MiaB accept sulfur from IscU [3] and are responsible for
the s2C32 [25] and ms2i(o)6A37 modification [26], respectively. The
unique tRNA thiolation pattern associated with sulfur transfer from
IscS to TusA, IscU or ThiI provides a convenient readout system to
assess the in vivo effects of IscS mutations on its interaction with
these proteins.
The proteins involved in sulfur utilization have been extensively
studied both functionally and structurally. Structures of IscS [27],
the sulfur acceptor proteins TusA [28], ThiI [29], IscU [30,31],
rhodanese [32], and the modulators human frataxin [33,34] and
its bacterial homologue CyaY [35,36], as well as IscX [16,37] have
been determined by X-ray crystallography or NMR. All of these
proteins adopt different folds and the acceptor proteins receive
sulfur from IscS by molecular mechanisms that are not fully
understood.
Despite this wealth of structural information, the question of
how IscS is able to communicate with such a broad spectrum of
proteins and deliver sulfur to a wide range of structurally divergent
partners is unresolved as no structural information on its
complex(es) with binding partner(s) is presently known. To begin
addressing this question, we have determined the crystal structure
of the IscS-TusA and the I cS-IscU complexes, which reveal
different modes of binding of these proteins and provide a
framework for understanding sulfur transfer from IscS. Further,
we performed extensive mutagenesis of the IscS surface followed
by in vitro (pull-down) and in vivo (tRNA complementation assay)
Figure 1. Network of protein-protein interactio s in olving IscS. Isc initiates intracellular sulfur trafficking, delivering the sulfur to several
sulfur-accepting proteins such as IscU, ThiI, TusA, and MoaD/MoeB that commit the sulfur to different metabolic pathways. IscU is the primary
scaffold for assembly of Fe-S clusters. Frataxin/CyaY has been postulated as an Fe chaperone, an Fe donor for Fe-S cluster assembly, or a regulator of




Sulfur is incorporated into the backbone of almost all
proteins in the form of the amino acids cysteine and
methionine. In some proteins, sulfur is also present as
iron–sulfur clusters, sulfur-containing vitamins, and cofac-
tors. What’s more, sulfur is important in the structure of
tRNAs, which are crucial for translation of the genetic code
from messenger RNA for protein synthesis. The biosyn-
thetic pathways for assembly of these sulfur-containing
molecules are generally well known, but the molecular
details of how sulfur is delivered from protein to protein
are less well understood. In bacteria, one of three
pathways for sulfur delivery is the isc (iron-sulfur clusters)
system. First, an enzyme called IscS extracts sulfur atoms
from cysteine. This versatile enzyme can then interact with
several proteins to deliver sulfur to various pathways that
make iron–sulfur clusters or transfer sulfur to cofactors and
tRNAs. This study describes in atomic detail precisely how
IscS binds in a specific and yet distinct way to two different
proteins: IscU (a scaffold protein for iron–sulfur cluster
formation) and TusA (which delivers sulfur for tRNA
modification). Furthermore, by introducing mutations into
IscS, we have identified the region on the surface of this
protein that is involved in binding its target proteins.
These findings provide a molecular view of the protein–
protein interactions involved in sulfur transfer and advance
our understanding f how sulfur is delivered from one
protein to another during biosynthesis of iron–sulfur
clusters.
IscS Interactions with Partner Proteins
PLoS Biology | www.plosbiology.org 2 April 2010 | Volume 8 | Issue 4 | e1000354
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the transfer to targed apo-proteins. To accept a sulfur atom IscU interacts with IscS, 
but the iron donor is still unknown, even if frataxin CyaY was suggested for this role. 
In vitro studies on A. vinelandii IscU showed that [2Fe-2S] clusters are assembled 
first and that reductive coupling between two of them produces one [4Fe-4S] cluster 
that can be then transferred (Agar, Krebs et al. 2000).  
Whereas IscU homologues generally have been described as dimers (as, for 
example, the IscU from Thermatoga maritima, an evolutionarily ancient 
hyperthermophilic bacterium) (Bertini, Cowan et al. 2003, Gerber, Muhlenhoff et al. 
2003) monomeric forms were identified for the human protein (Gerber, Muhlenhoff 
et al. 2003) and for Haemophilus influenzae and E. coli IscUs (Adinolfi, Rizzo et al. 
2004). Adinolfi et al. showed that E. coli IscU is well folded with a high melting 
temperature and reversibility of the thermal unfolding curve (Adinolfi, Rizzo et al. 
2004). 
IscU exists as two slowly interconverting species: a conformation (S-state) largely 
structured and the other (D-state) partially dynamically disordered (Kim, Fuzery et 
al. 2009). In both crystal and NMR structures of IscU, a zinc metal ion is found in the 
site which hosts the cluster coordinated by three conserved cysteine residues and 
one conserved aspartate. (Ramelot, Cort et al. 2004, Liu, Oganesyan et al. 2005, 
Kornhaber, Snyder et al. 2006, Bonomi, Iametti et al. 2011). This cation is thought to 
stabilize the folded form (Markley, Kim et al. 2013). For this reason, Zn2+ is often 
introduced in the culture medium to facilitate IscU expression in the stably folded 
form (Prischi, Pastore et al. 2010). The presence of zinc does not alter the 
interaction with the enzyme IscS, that is probably the most important of the natural 
partners of cluster-free IscU, and it increases the Fe-S cluster formation by 
preventing oxidation of the cysteines until the cluster is in place and this ion can 
readily be expelled (Iannuzzi, Adrover et al. 2014). 
 
1.3.4 IscA 
Although IscA orthologues maintain a high degree of evolutionary conservation, its 
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role is yet unknown. Bilder et al. solved and refined the 2.3 Å resolution crystal 
structure of E. coli IscA, a polipeptide of 107 residues with a novel fold in which 
mixed β-sheets form a compact α-β sandwich domain (Bilder, Ding et al. 2004). 
Three cysteine residues (Cys35, Cys99, Cys101) in IscA are implicated in Fe-S 
cluster binding (Bilder, Ding et al. 2004) and it has been proposed to function as an 
alternative scaffold protein for assembling and transfer of Fe-S clusters (Krebs, Agar 
et al. 2001, Bonomi, Iametti et al. 2005). Holo-IscA and eukaryotic homologues of 
IscA have been shown to complex and transfer [2Fe-2S] clusters to the apo-form of 
E. coli ferredoxin, another protein synthesized from the isc operon (Jensen and 
Culotta 2000, Ollagnier-de-Choudens, Mattioli et al. 2001). IscA also has high 
affinity for iron and it may serve as an iron-delivery protein (Ding and Clark 2004, 
Ding, Clark et al. 2004).  
 
1.3.5 HscA and HscB 
The hscA and hscB genes of Escherichia coli encode novel chaperone and co-
chaperone proteins, designated HscA and HscB, respectively. They represent a 
molecular system similar to the prokaryotic DnaK/DndJ and the eukaryotic 
hsp70/hsp40 systems (Vickery, Silberg et al. 1997) where chaperone DnaK is an 
enzyme with a weak ATPase activity stimulated by its interaction with another co-
chaperone, DnaJ (Vickery, Silberg et al. 1997). 
HscB structure consists in 8 helices and is divided in two domains: the C-terminal 
domain (95 residues) is involved in binding the substrate, IscU, whereas the N-
terminal J-domain (76 residues) is responsible for the interaction with HscA (Walsh, 
Bursac et al. 2004). 
 
	   30	  
 
Figure 1.6 Sequence chain view of HscB as reported in PDB (ID entry 1FPO). Red curve indicates 
an alpha helix, pink curves a 3/10-helix, green curve indicates a turn and light green line a bend. 
 
Purified HscA exhibits a low intrinsic ATPase activity (∼0.6 min-1 at 37°C and pH 
7.5), and HscB was found to stimulate this activity up to 3.8-fold. To better 
understand the mechanism and regulation of HscA, Silberg and Vickery investigated 
the kinetics of ATP hydrolysis and proposed a model for the ATPase reaction cycle. 
HscA binds ATP in a two-step process in which HscA is converted from a high 
peptide affinity (R-state) to a low peptide affinity (T-state). The ATP hydrolysis is the 
rate limiting step and it seems likely to be subject to co-chaperone regulation 
(Silberg and Vickery 2000). 
 
 
Figure 1.7 Kinetic scheme of the HscA ATPase reaction cycle. In the scheme HscA is indicated as 
Hsc66 and Hsc66‡	  represents the T-state (Silberg and Vickery 2000). 
 
HscA interacts with the scaffold protein IscU. The binding was shown to stimulate its 
ATPase activity (Hoff, Silberg et al. 2000) and ATP destabilizes HscA-IscU 
cycle as shown in Scheme 1.
Hsc66 Binds ATP in a Two-step Process—Hsc66 binds ATP
in a two-step process pr ceding hydrolysis as evidenced by he
rapid, biphasic, ATP-induced change in Hsc66 absorbance. The
rate constant describing the rapid phase of this spectral change
(kfast) is interpreted as arising from formation of an Hsc66!ATP
collision complex (Hsc66!ATP) since kfast increases linearly
with ATP concentration. The rate constant describing the sec-
ond slower phase of the ATP-induced spectral change (kslow) did
not vary with ATP concentration and is interpreted as arising
from a unimolecular process that follows ATP binding. In pre-
vious studies, we found that ATP destabilizes Hsc66!peptide
complexes (21) indicating that either ATP binding or the sub-
sequent unimolecular step affect the conformation of the pep-
tide binding domain of Hsc66. We therefore interpret kslow as
representing a slow, conformational change (kconf) converting
Hsc66 from a high peptide affinity R state to a low peptide
affinity T state (Hsc66‡!ATP).
ATP Hydrolysis Is Rate-limiting in the Forward Reaction
Cycle—ATP hydrolysis occurs with similar rates under both
single turnover and steady-state conditions indicating that khyd
is rate-limiting in the forward reaction cycle. Since this kinetic
step occurs with a rate that is !70-fold slower than any other
forward step in the reaction cycle, it seems likely that khyd will
be subject to cochaperone regulation as has been reported for
other hsp70 family members (14–17). ATP hydrolysis also ap-
pears to be irreversible on the time course of physiological
processes since a maximum of one 18O was incorporated into
inorganic phosphate when ATP hydrolysis reactions were per-
formed in H2
18O.
Under single turnover conditions, the ATP-induced differ-
ence spectrum decays to that resembling the spectrum in the
presence of ADP and Pi with a rate (kdecay) essentially equal to
the rate of ATP hydrolysis. This finding can be explained by a
two-step sequential mechanism, in which ATP hydrolysis pre-
cedes a conformational change that results in a decay of the
ATP-induced difference spectrum. Previous studies showed
that Hsc66!peptide complexes are stabilized in the presence of
ADP (21). We therefore interpret this hydrolysis-induced spec-
tral change as representing a conformational change in Hsc66
converting it from the T state (low peptide affinity) to the R
s ate (high peptide affinity). Because the observed spectral
transition occurs with a rate similar to that observed for ATP
hydrolysis, it seems likely that this conformational change
occurs with a rate that is faster than that for ATP hydrolysis
(!0.0014 s"1).
Nucleotide Exchange Is Rapid Compared with ATP Hydrol-
ysis—Analysis of the concentration dependence of ADP-in-
duced absorbance changes indicates that the rate of ADP
dissociation is !103-fold faster than the rate of ATP hydrol-
ysis (khyd # 0.0014 s
"1) both in the absence (kd
ADP # 60 s"1)
and in the presence of physiological levels of phosphate
kd
ADP(Pi) # 9.1 s"1). In addition, the rate of phosphate disso-
ciation (kd
Pi ! 12 s"1) was found to be $104-fold faster than
the rate of ATP hydrolysis in the absence of ADP. The fast
ADP and Pi dissociation rates, taken together with the pre-
diction that ATP binding will be extremely fast in vivo where
the ATP concentration is high ($3 mM in logarithmically
growing E. coli; Ref. 44), indicates that the rate of ADP/ATP
exchange should be !103-fold faster than the rate of ATP
hydrolysis. The rate of ADP/ATP exchange, therefore, should
have little effect on the steady-state ATPase rate. Thus, the
high peptide affinity R state (Hsc66!ADP) is expected to be
short lived compared with the low affinity T state
(Hsc66‡!ATP) in the absence of auxiliary factors and under
conditions where ATP levels are high.
Comparison with the ATPase Reaction Cycle of DnaK—Com-
parison of our findings for Hsc66 and those published for DnaK
(11–13) reveals a number of differences in the kinetics of their
respective ATPase reaction cycles. Hsc66 exhibits a !103-fold
lower affinity for both ATP and ADP compared with values for
DnaK. The low nucleotide affinity of Hsc66 explains the lack of
bound nucleotides in purified preparations of Hsc66 as well as
the lack of binding of Hsc66 to an ATP affinity resin (22). The
nucleotide association rates of Hsc66 and DnaK are similar,
but the dissociation rates of Hsc66 are !103-fold faster than
those of DnaK and account for the differences in their ADP and
ATP affinities. ADP dissociation from DnaK, however, is sub-
ject to regulation by the nucleotide exchange factor GrpE (45)
which stimulates the rate of ADP release $103-fold (17) to a
level which is similar to the intrinsic rate predicted for Hsc66.
GrpE does not affect Hsc66 (21), and because the rates of ADP
release and ATP binding to Hsc66 are already very fast, ADP/
ATP exchange may not be subject to further stimulation by an
auxiliary protein as is the case for DnaK.
For DnaK the rate of ADP release is similar to that of ATP
hydrolysis (11–13), whereas for Hsc66 the rate of ADP re-
lease is !103-fold faster than the rate of ATP hydrolysis.
Thus, although there will be a close balance between the R
and T states for DnaK, the R N T equilibrium will be shifted
SCHEME 1. Kinetic scheme of the Hsc66 ATPase reaction cycle.
See text for discussion.
TABLE I
Summary of experimental results for kinetic measurements of Hsc66
catalyzed ATP hydrolysis at 23 °C
Km ("M) 12.7 % 1.8
kcat (s"1) 0.00138 % 0.00005
khydrolysis (s"1) 0.00143 % 0.00002
ksynthesis (s"1)a #3 & 10"5
kdecay (s"1) 0.00126 % 0.00003
kaATP (M"1 s"1) 4.2 % 0.4 & 104
kdATP (s"1) 1.1 % 0.3
KdATP calculated ("M) 26 % 7
kconf (s"1) 0.10 % 0.03
kaADP (M"1 s"1) 7.0 % 0.9 & 105
kdADP (s"1) 60 % 9
KdADP calculate ("M)b 87 % 17
KdADP measured ("M)c 51 % 4
kaADP(Pi) (M"1 s"1)d 0.28 % 0.04 & 105
kdADP(Pi) (s"1)d 9.1 % 1.2
KdADP(Pi) calculated ("M)bd 325 % 60
KdADP measured ("M)cd 248 % 36
KdPi (mM) 0.73 % 0.03
kdPi (s"1) !12.1 % 0.4
a Values at 37 °C.
b Equilibrium dissociation constants were calculated by dividing dis-
sociation rate constants by their respective association rate constants.
c Values at 25 °C.
d Kinetic parameters were determined in the presence of 10 mM
inorganic phosphate.
Kinetic Analysis of the Hsc66 ATPase Reaction Cycle 7785
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complexes (Silberg, Hoff et al. 2001). HscA may assist in Fe-S cluster formation by 
maintaining IscU in a conformation suitable for cluster assembly; alternatively, HscA 
may facilitate the transfer of the cluster from holo-IscU to an acceptor apo-protein 
(Hoff, Silberg et al. 2000). IscU also directly interacts with HscB, and HscB may 
serve to control the association of IscU with HscA because in its presence, the 
affinity of IscU for HscA is increased >18-fold. HscB also has a synergistic effect on 
the IscU stimulation of the ATPase activity of HscA, increasing the rate >50-fold 
over that found at saturating levels of IscU alone (Hoff, Silberg et al. 2000). To 
better understand the mechanism by which HscB and IscU regulate HscA, Silberg et 
al. examined their binding to the different conformational states of HscA and their 
effects on the kinetics of the individual steps of the ATPase reaction cycle (Silberg, 
Tapley et al. 2004). Whereas IscU binds both ADP (R-state) and ATP (T-state) 
HscA complexes, HscB interacts only with an ATP-bound state. Both IscU and HscB 
modestly accelerate the rate-determining steps in the HscA reaction cycle, the 
hydrolysis of ATP. Furthermore, when present together an enhancement of 
HscA(ADP)-IscU complex formation is observed. Following the ADP/ATP exchange, 
IscU seems also to stimulate the HscA transition from the R to the T-state and 
thereby accelerates the rate at which the HscA-ATP is regenerated (Silberg, Tapley 
et al. 2004). 
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Figure 1.8 A model for the IscU binding cycle of HscA. Kinetic constants shown correspond to rates 
in the presence of IscU and HscB (Silberg, Tapley et al. 2004). 
 
Kinetic studies of Fe-S cluster transfer from holo-IscU to apo-Fdx in the presence of 
T. maritima chaperone DnaK demonstrated an inhibitory effect on the rate of Fe-S 
cluster transfer from IscU (Wu, Mansy et al. 2005). In contrast with this result, 
Chandramouli et al. showed that HscA/HscB facilitate [2Fe-2S] cluster transfer in 
vitro from the holo-IscU scaffold protein to apo-Fdx and that cluster transfer 
involving IscU is an ATP-dependent process (Chandramouli and Johnson 2006). 
However, in the presence of the only HscB, the cluster assembled on IscU is 
transferred to apo-FdX at slower rate than those formed in the absence of HscB 
unless ATP and HscA are also present. (Bonomi, Iametti et al. 2008, Iametti, 
Barbiroli et al. 2015). 
 
1.3.6 Ferredoxin (FdX) 
E. coli isc ferredoxin contains a [2Fe-2S] centre and it is demonstrated that the 
cluster transfer from IscU to the apo-Fdx is a key step for its activation (Wu, Mansy 
et al. 2005). IscS binds Fdx with a mainly electrostatic mechanism that involves 
complementary surfaces of opposite charge. Fdx leaves the interaction of IscS with 
IscU unchanged, but it competes for the same binding site that accommodates 
Table I. A diagrammatic model illustrating the different nucle-
otide-bound states of HscA involved in substrate binding and
release is shown in Fig. 8.
The HscA Chaperone Cycle—As is characteristic of hsp70-
type chaperones, HscA couples ATP binding and hydrolysis
with conformational changes that control substrate affinity (2).
ATP binding leads to formation of a tense state (T) with re-
duced substrate affinity and increased substrate exchange
rates, and ATP hydroly is to ADP and phosphate result in a
relaxed state (R) with increased substrate affinity and de-
creased substrate exchange rates (3). In the absence of co-
chaperone and substrate, the steady-state reaction rate and
cycling between R- and T-states is very slow (kcat ! 0.002 s
"1).
Under these conditions the rate of the cycle is determined by the
rates of ATP hydrolysis (khyd) and T3R conversion (kT3R), and
ucleotide exchange (kd
ADP and ka
ATP) is #103-fold faster than
these steps (11). IscU enhances R3T conversion (kR3T), and
IscU and HscB stimulate khyd and kT3R such that the rate of
cycling through the different conformational states can be accel-
erated more than 500-fold. Even in the presence of saturating
amounts of substrate and co-chaper ne, however, ATP hydrolysi
and T3R conversion remain rate-determining in the steady-
state reaction cycle.
Substrate Binding—We showed previously that IscU is a
specific substrate for HscA, binding to ADP and ATP complexes
of HscA with KD values of 1.6 and 34 !M, respectively (3, 4).
HscB also binds IscU and enhances HscA binding of IscU under
steady-state-turnover conditions, lowering the concentration of
IscU necessary for half-maximal stimulation of HscA ATPase
activity to a level (Km ! 1.8 !M) that is similar to the affinity of
HscA!ADP for IscU. The SPR measurements presented here
establish that HscB only interacts with the ATP complex of
HscA suggesting that HscB acts specifically to recruit IscU to
the low affinity T-state (HscA‡!ATP). This type of role for HscB
is upported by earlier findings with IscU mutants which
showed that HscB could override binding defects caused by
substitutions within the LPPVK recognition motif of IscU (7).
Together, these results indicate that the ternary complex
HscA‡!ATP-HscB-IscU is more stable than binary complexes of
HscA‡!ATP with substrate or co-chaperone alone.
Substrate Capture—ATP hydrolysis measurements per-
formed under single-turnover conditions revealed that HscB
and IscU individually stimulate the rates of ATP hydrolysis
and T3R conversion only modestly, $10- and 3-fold, respec-
tively. When both co-chaperone and substrate are present,
however, khyd and kT3R were synergistically accelerated to a
level that is much faster than the additive effects of the indi-
vidual proteins. In the presence of saturating levels of co-
chaperone and substrate, ATP hydrolysis occurred with a rate,
$1 s"1, faster than IscU dissociation from immobilized
HscA‡!ATP (kobs $ 0.15–0.35 s
"1; Fig. 7) (3). T3R conversion
is expected to occur concurrently with ATP hydrolysis, because
khyd and kT3R were observed to have essentially identical rates
under all conditions assayed. These findings suggest that IscU
will remain bound to HscA and be effectively trapped in the
high affinity R-state HscA!ADP complex. HscB is expected to
dissociate from this complex, because HscB does not interact
with HscA!ADP even in the presence of IscU.
Substrate Release—IscU binds with high affinity to the R-
state HscA!ADP complex. This complex must dissociate ADP %
Pi, bind ATP, and undergo R3T conversion to regenerate the
low affinity T-state HscA‡!ATP. In the absence of IscU, the rate
of this process is determined by R3T conversion, because kR3T
exhibits a rate that is 102-fold slower than the intrinsic nucle-
otide exchange rate ($10 s"1; cf. Ref. 11). The findings pre-
sented here show that IscU enhances R3T conversion $50-
fold. This effect reduces the lifetime of the HscA-IscU complex
and serves as an auto-regulatory mechanism to allow addi-
tional cycles of substrate binding and release.
Comparison with the DnaK/DnaJ Chaperone System—The
effects of IscU and HscB on HscA ATPase activity are in gen-
eral similar to the effects of peptide substrates and DnaJ on
DnaK. Peptide substrates stimulate DnaK ATP hydrolysis
weakly (15–18), and DnaJ, when used at concentrations ap-
proximating in vivo levels, exerts a weak stimulatory effect on
DnaK ATP hydrolysis (14, 15 ,17, 18), Substrate-bound DnaJ
dramatically accelerates the rate of DnaK ATP hydrolysis (15,
18) as we find for IscU bound to HscB. These similarities
suggest that DnaJ and HscB both tightly couple regulation of
ATP hydrolysis to substrate capture by the high peptide affin-
ity conformation of their respective chaperone partners. For
DnaK, the large acceleration of ATP hydrolysis has been at-
tributed to simultaneous interactions of the DnaJ J-domain
with the DnaK ATPase domain and of the peptide substrate
with the DnaK substrate binding domain (15, 18, 21, 22). The
similarity of the structure of the J-domain of HscB (24) to that
of DnaJ (34, 35) suggests that both co-chaperones regulate the
ATPase activity of HscA by a similar mechanism. Despite dif-
ferences in the orientation of the peptide region of IscU bound
to substrate binding domain of HscA (9) compared with the
peptide complex of DnaK (10, 36–38), IscU appears to regulate
the ATPase activity of HscA by a mechanism similar to that of
DnaK substrates.
Although the mechanism of regulation of the ATPase activity
and substrate capture by HscA and DnaK are similar, the
kinetics and regulation of substrate release are different. Both
HscA!ADP and DnaK!ADP substrate complexes require ADP/
ATP exchange and subsequent R3T conversion to generate
the low peptide affinity forms. For DnaK, nucleotide exchange
is believed to determine the rate at which the low peptide
affinity T-state (DnaK‡!ATP) is regenerated, because ADP dis-
sociation occurs with a rate that is significantly slower than
R3T conversion (16, 39–41). In the case of HscA, nucleotide
exchange and R3T conversion are both fast (#1 s"1) and are
orders of magnitude faster than DnaK ADP/ATP exchange.
Thus, in the absence of auxiliary proteins, the half-life of a
FIG. 8. A model for the IscU binding cycle of HscA. Kinetic
constants shown correspond to rates in the presence of IscU and HscB;
additional values are given in Table I. See text for “Discussion.”
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bacterial frataxin CyaY (Yan, Konarev et al. 2013) and at least two other proteins, 
YfhJ, which belongs to the Isc system, and TusA, a protein responsible of delivering 
sulfur for tRNA modification (Shi, Proteau et al. 2010). In vivo Fdx may carry out the 
role of the reducing agent required for accelerating reduction of S0 to S2- in the 
transfer step from the persulfide of IscS to the [2Fe-2S] cluster on IscU and 
regenerating the reaction (Yan, Adinolfi et al. 2015). As prove of that it was shown 
that the presence of Fdx is sufficient for the IscS enzymatic reaction to occur without 
the need of other reducing agents (Kim, Frederick et al. 2013).  
 
1.3.7 YfhJ 
The last isc operon gene encodes YfhJ (also called ORF3 or IscX) (Tokumoto and 
Takahashi 2001), a small, acidic protein of 66 residues. Very little is known about 
this protein and its role is still not clear. It is supposed to be not essential because it 
is exclusively present in prokaryotes. In solution YfhJ is stably folded in a compact 
globular domain (Pastore, Adinolfi et al. 2006) and crystal structure of YfhJ exhibits 
five α-helices organized in a helix-turn-helix motif typical of DNA-binding proteins, 
suggesting a function as a transcription regulator of the isc operon. However it is 
unlikely that YfhJ binds to DNA because the surface of YfhJ presents a negatively 
charged patch (Shimomura, Takahashi et al. 2005). In vitro experiments have 
shown an interaction between YfhJ and IscS (Tokumoto, Nomura et al. 2002) 
indicating that YfhJ is involved in the Isc function modulating this protein (Pastore, 
Adinolfi et al. 2006). YfhJ seems to be able to bind both Fe2+ and Fe3+ but with 
modest affinity since equimolar ratios of frataxin CyaY are able to compete partially 
with the binding. Furthermore the surface involved in binding IscS is the same as 
that implicated in iron binding and the binding affinity to IscS is modulated by the 
presence of iron cations. In addition, YfhJ and frataxin CyaY compete for the same 
site on IscS (Prischi, Konarev et al. 2010, Shi, Proteau et al. 2010, Kim, Bothe et al. 
2014). This strongly suggests that YfhJ could be a molecular adaptor that mediates 
the interaction of IscS with a yet unidentified partner through an iron-mediated 
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mechanism (Pastore, Adinolfi et al. 2006). 
1.4 Mechanism of Fe-S cluster assembly mediated by the Isc 
system 
The Fe-S cluster biosynthesis is a complicated process that still needs to be 
elucidated. However it could be simplified in two steps: first the Fe-S cluster is 
assembled on IscU that acts as a scaffold protein, then the Fe-S cluster is 
transferred to a target apo-protein (Ayala-Castro, Saini et al. 2008).  
 
 
Figure 1.9 Fe-S cluster biosynthesis could be simplified in two steps: sulfur is liberated by the 
cysteine desulfurase IscS and donated to the scaffold protein IscU for nascent Fe-S cluster assembly. 
The Fe-S cluster is then transferred to a target apoprotein.  
 
After IscS has catalyzed the desulfurization of L-cysteine to produce L-alanine and 
sulfur, the sulfur atom is transferred directly from IscS to IscU via the formation of an 
IscS-IscU covalent complex: a disulfide bond was found between Cys328 of IscS 
and Cys63 of IscU. The covalent bond between these two proteins is produced only 
in the presence of L-cysteine, the substrate for IscS. Since it is indispensable for 
IscS activation it was supposed that the target of IscU is IscS with sulfane sulfur 
derived from L-cysteine attached at Cys328 (Kato, Mihara et al. 2002). Once iron is 
bound, the release of persulfide sulfur (S0) to the metal cluster as sulfide (S2-) 
requires reduction. (Urbina, Silberg et al. 2001). 
This process in vitro is facilitated by the non-physiological reducing agent DTT but it 
is known that FdX could be the molecule responsible for electron transfer in Fe-S 
/ƐĐ^ ĂƉŽƉƌŽƚĞŝŶ/ƐĐh
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cluster biogenesis (Yan, Adinolfi et al. 2015). Curiously Markley et al. proposed that 
IscS binds preferentially to the disordered D-state of IscU. By selecting the D-state, 
IscS ensures that the cysteine residues of IscU are unligated by metals and 
available to react with the sulfur generated by the catalytic conversion. With cluster 
formation, IscU converts to the S-state, which has a lower affinity for IscS (Markley, 
Kim et al. 2013) but is selectively recognised by HscB (Kim, Fuzery et al. 2009).  
Then the holo-IscU-HscB complex represents a target for HscA in its ATP-bound 
form. After the formation of HscA(ADP), the equilibrium between IscU conformations 
is shifted to the D-state ensuring release of the cluster and HscB (Kim, Tonelli et al. 
2012). Chandramouli et al. studied the cluster transfer from IscU to target apo-
ferredoxin mediated by HscA and HscB chaperones. Since ATP hydrolysis and the 
presence of HscB accelerate this process, they suggest that conformational 
changes accompanying the ATP (T-state) to ADP (R-state) transition in the HscA 
chaperone are required for catalysis. ATP binding to HscA leads to a tense (T) state 
with decreased substrate-binding affinity. HscB binds and escorts IscU to HscA and 
enhances HscA binding of IscU in the ATP-bound T-state, leading to a transient 
HscA-ATP-HscB-IscU complex which undergoes ATP hydrolysis and loss of HscB 
to yield an ADP-bound relaxed (R) state with increased affinity for IscU. The IscU 
substrate is subsequently released after ADP/ATP exchange and the R to T 
transition that occurs following ATP binding to HscA. They proposed two 
mechanistic schemes for chaperone-catalyzed Fe-S cluster transfer from [2Fe-2S]-
IscU to apo-acceptor proteins. The first involves direct coupling between ATP 
hydrolisis and cluster transfer and requires interaction between apo-FdX and the T-
state HscA-ATP-HscB-IscU complex. The second involves ATP hydrolysis 
preceding cluster transfer and involves interaction between apo-FdX and the R-state 
HscA-ADP-IscU complex (Chandramouli and Johnson 2006). The chaperones could 
act by causing changes in IscU conformation that facilitate cluster release or capture 
by the acceptor protein (Bonomi, Iametti et al. 2008). HscA binds IscU via a 
conserved 99LPPVK103 sequence (Hoff, Ta et al. 2002, Hoff, Cupp-Vickery et al. 
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2003, Cupp-Vickery, Peterson et al. 2004) positioned close to the conserved 
Cys106 that may be involved in the cluster coordination. Conformational changes 
coupled to the HscA T-state to R-state transition during ATP hydrolysis may act to 
make the cluster more available (Bonomi, Iametti et al. 2008). 
 
 
Figure 1.10 Possible mechanistic schemes for chaperone-catalyzed Fe-S cluster transfer from 
[2Fe2S]-IscU to apo-FdX (Chandramouli and Johnson 2006). 
 
Although several attempts have been performed to clarify the molecular bases of 
the Fe-S cluster formation, they still appear to be not completely understood. 
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2. FRIEDREICH’S ATAXIA AND FRATAXIN 
Dysfunctions in Fe-S protein biogenesis and in mitochondrial iron homeostasis in 
heart and neurones cause pathological conditions, such as the neurodegenerative 
diseases Friedreich’s ataxia.  
 
2.1 Friedreich’s ataxia: symptoms and causes 
Nerves and cells of the heart muscle respire exclusively aerobically, so that they are 
totally dependent on mitochondrial oxidative phosphorylation. Mitochondrial 
dysfunction usually causes both myopathy and neuropathy and very often, the two 
occur together. Often mitochondrial myopathies are caused by mutations in the 
mitochondrial genome and more rarely these are found in nuclear-encoded 
enzymes of mitochondrial intermediary metabolism (Gibson, Koonin et al. 1996). 
Ataxia, meaning impaired movement due to loss of motor coordination, is 
associated with many of the mitochondrial myopathies, and in these cases is usually 
due to progressive neural degeneration (Gibson, Koonin et al. 1996). 
Friedreich’s ataxia (FRDA) is the most frequent hereditary ataxia occurring with a 
frequency of about 1:30000 to 50000 people within Caucasian populations and it 
presents a onset typically before age of 25 years and a mortality between 40 and 50 
years (Ashley, Hoang et al. 2012). It is characterized by a variety of symptoms, as 
progressive gait and limb ataxia, dysarthria, lower limb areflexia, decreased 
vibration sense, muscular weakness of the legs, positive extensor plantar response, 
hypertrophic cardiomyopathy and, often, diabetes mellitus or carbohydrate 
intolerance. Most neurological symptoms are a consequence of degeneration of the 
large sensory neurons of dorsal root ganglia and spinocerebellar tracts. The disease 
primarily affects neurones with very long axons, which appear to die back from the 
periphery (Gibson, Koonin et al. 1996, Schmucker and Puccio 2010). 
FRDA is an autosomal recessive disease and it is associated with the mutation of a 
gene mapped to chromosome 9q13–q21 which encodes a small mitochondrial 
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protein called frataxin (Gibson, Koonin et al. 1996). The most common mutation is a 
GAA triplet-repeat expansion within the first intron of the frataxin gene. In healthy 
patients, the number of repeats ranges from 6 to 36 repeats, whereas in FRDA 
patients, the number of repeats ranges from 70 to 1700 repeats, most commonly 
600 to 900 GAA. The severity of the disease correlates with the number of repeats. 
While most patients (96%) carry two expanded GAA alleles, which lead to strongly 
reduced frataxin expression in all tissues, 4% of FRDA patients present a (GAA)n 
mutation on one allele and a micromutation on the other. These mutations are small 
deletions or point mutations that can disturb the normal function of frataxin, either by 
affecting protein folding or by affecting functional residues (Schmucker and Puccio 
2010). An exemple is point mutation G137V that does not impair the structure or the 
activity of frataxin but reduces the folding stability (Faggianelli, Puglisi et al. 2015).  
Frataxin-defective organisms exhibit iron metabolism and other metabolic 
disturbances and damage caused by oxidative stress. The first evidence is the iron 
accumulation in the mitochondria of heart cells and neurones correlated with deficit 
of iron-sulfur clusters synthesis, a process in which frataxin is directly involved. This 
causes dysfunction of Fe-S cluster enzymes (Pandolfo and Pastore 2009). 
In addition, an increase of H2O2 levels is observed. Impairment of the respiratory 
complexes I, II, and III containing Fe-S clusters lead to a decrease of the respiratory 
chain activity. Direct addition to oxygen of electrons from the leakage of the 
defective respiratory chain generates O2–. In mitochondria superoxide dismutase2 
(SOD2) catalyses dismutation of superoxide (O2–) with formation of H2O2. Cells from 
FRDA patients show highly sensitivity to hydrogen peroxide: H2O2 generates the 
highly toxic hydroxyl radical (OH!) by reacting with Fe2+ (Fenton reaction) and OH! 
damages proteins, lipids, and nucleic acids. H2O2 is eliminated by mitochondrial 
glutathione peroxidase, at the expense of the small-molecule anti-oxidant 
glutathione, which appears to be decreased, possibly because of an excess of 
consumption (Tozzi, Nuccetelli et al. 2002). 
For reasons that are unclear, frataxin-deficient cells also seem to have a reduced 
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ability to activate antioxidant defenses (Pandolfo and Pastore 2009) and FRDA 
patients exhibit increases in nuclear and mitochondrial DNA damage (Schmucker 
and Puccio 2010). Additional abnormalities in multiple metabolic pathways have 
been revealed. In particular, defects in heme synthesis, sulfur amino acid 
metabolism, energy metabolism, stress response, and mitochondrial function 
(Pandolfo and Pastore 2009).  
 
2.2 Frataxin: structure and function 
Frataxin is a ubiquitous mitochondrial protein that is highly concentrated in the cells 
of heart, spinal and dorsal root ganglia (Koutnikova, Campuzano et al. 1997). It is 
present in living organisms ranging from bacteria to humans and it seems to be 
essential for survival (Gibson, Koonin et al. 1996). Frataxin is highly conserved and 
orthologues of frataxin as bacterial frataxin (named CyaY) and yeast frataxin 
(named Yfh1) are currently in use as model systems for understanding the 
properties of the frataxin family (Adinolfi, Trifuoggi et al. 2002). 
Frataxin is composed, in humans, of 210 amino acids and the protein, after the 
mitochondrial import sequence cleavage, forms two structurally distinct regions. 
Among these only the evolutionary conserved C-terminus is folded and forms a 
compact globular domain with a stable β-sheet consisting of seven strands packed 
against a pair of parallel helices (Musco, Stier et al. 2000). 
The bacterial frataxin, CyaY, is a highly acidic protein consisting of 106 residues. 
NMR and crystallographic structural studies on human frataxin and crystallographic 
studies on bacterial frataxin revealed a similar fold for both proteins, even if no 
similarity to known protein folds in the protein databases were found (Nair, Adinolfi 
et al. 2003). Comparing the C-terminus length of CyaY with that of human frataxin, it 
was shown that in bacteria it is nine residues shorter than in human. The length of 
this tail has been demonstrated to be an important factor influencing the intrinsic 
thermal stability in vitro (Adinolfi, Nair et al. 2004, Sanfelice, Puglisi et al. 2014). 
By testing the effects of individual residue mutations that cause the disease, it was 
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discovered that all missense mutations observed map in the evolutionary conserved 
frataxin C-terminus, supporting the hypothesis that the C-terminus is the functionally 
most relevant region of the protein (Musco, Stier et al. 2000). The most common 
frataxin mutants associated to Friedreich’s ataxia retain the native fold under 
physiological conditions, but have a reduced thermodynamic stability, a higher 
tendency towards proteolytic digestion (Correia, Adinolfi et al. 2006) and an 
enhanced tendency to aggregate (Correia, Pastore et al. 2008). 
The structure is compact with no grooves or cavities. However, an exposed surface 
of negatively charged and conserved residues responsible for iron binding can be 
identified (Musco, Stier et al. 2000). Frataxin has poor sequence homology with 
other known proteins involved in iron or heme metabolism and the iron binding 
surface involves a region that contains mainly carboxylate residues, but not residues 
traditionally observed in other non-heme iron binding proteins, such as histidine, 
cysteine, or tyrosine (Nair, Adinolfi et al. 2004). Investigating iron donor proteins, 
Yoon and Cowan demonstrated that human frataxin is able to bind from six to seven 
iron ions (Yoon and Cowan 2003). The bacterial hortologue CyaY is able to bind 
iron as well, but with low selectivity (Pastore, Franzese et al. 2007). Low affinity in 
the iron binding and formation of a transient complex are clues of a role as iron 
carrier in the cell: it was supposed that frataxin could pass iron on to other proteins 
with an iron storage mechanism in order to keep iron in a bio-available and non-
toxic form (Gakh, Adamec et al. 2002). Some reports have shown that frataxin is 
able to donate iron to IscU (Yoon and Cowan 2003), ferrochelatase (Yoon and 
Cowan 2004), and aconitase (Bulteau, O'Neill et al. 2004). Layer et al. 
demonstrated that the bacterial frataxin orthologue, CyaY, in vitro is able to provide 
iron to the bacterial scaffold IscU in the presence of the cysteine desulfurase IscS 
and cysteine to generate Fe-S cluster (Layer, Ollagnier-de Choudens et al. 2006). 
IscS binds monomers of CyaY with a 1:1 stoichiometry and, contrary to what was 
observed for human frataxin with the scaffold protein ISU (Yoon and Cowan 2003), 
contacts with IscU are possible only in the context of the ternary complex with IscS 
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(Prischi, Konarev et al. 2010). The surface of interaction with the desulfurase 
involves a direct recognition of the negatively charged region of CyaY, that 
corresponds to the iron binding surface, by a positively charged patch on IscS, thus 
rendering an active role of iron in complex formation unlikely (Foury, Pastore et al. 
2007). 
It was reasoned that if frataxins were iron providers, the presence of CyaY should 
either enhance the enzymatic rates of the Fe-S cluster formation or otherwise have 
no effect. On the contrary, the presence of CyaY inhibits the reaction. In particular 
CyaY seems not to alter the IscS desulfurase activity but it is an inhibitor of cluster 
formation and its effect does not depend on the specific acceptor. Since conversion 
of cysteine into alanine is unperturbed by the presence of CyaY (Adinolfi, Iannuzzi 
et al. 2009), it could interfere with the sulfur transfer from IscS to IscU, impairing the 
motions of the flexible catalytic loop containing Cys328 or increasing the affinities 
between IscU and IscS through the stabile ternary complex, thus decreasing the 
dissociation rate constant (Prischi, Konarev et al. 2010). 
In contrast of CyaY, human frataxin activates both the cysteine desulfurase and Fe-
S formation reactions (Tsai and Barondeau 2010). To solve this discrepancy, 
enzyme kinetic experiments were performed by Bridwell-Rabb et al. interchanging 
analogous cysteine desulfurase, Fe-S assembly scaffold, and frataxin components 
for the human and E. coli systems (Bridwell-Rabb, Iannuzzi et al. 2012). They 
observed that activation or inhibition by the frataxin homologue is not controlled by 
the frataxin itself but rather dictated by the cysteine desulfurase: addition of bacterial 
or human frataxin inhibits Fe-S assembly by complexes of bacterial desulfurase and 
activates Fe-S assembly by complexes containing human desulfurase, albeit 
inhibition of the E. coli complex by CyaY was more efficient than by human frataxin 
and activation of the human complex by human frataxin was more efficient than by 
CyaY. They suggest that binding of the effector molecule switches the activity, either 
from “off” to “on” or from “on” to “off”. It was supposed that CyaY modulates the Fe-
S cluster formation by inducing an “off” conformation of bacterial system, on the 
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other hand the human frataxin is able to trap an “on” conformation of human 
complex (Bridwell-Rabb, Iannuzzi et al. 2012). 
 
 
Figure 2.1 Working model for frataxin regulation of Fe-S cluster biosynthesis. Fe-S cluster 
assembly complex exists as a mixture of functional and nonfunctional states, which are stabilized by 
binding of frataxin homologues. In eukaryotes, a pre-equilibrium model is proposed in which the Fe-S 
cluster assembly deficient form is favored over the functional form. Frataxin binding stabilizes the 
functional form. In contrast, the prokaryotic complex that lacks frataxin exhibits activities of cysteine 
desulfurase and Fe-S cluster assembly. Frataxin binding abolishes Fe-S cluster synthesis (Bridwell-
Rabb, Iannuzzi et al. 2012). 
 
The effect of CyaY on Fe-S cluster formation is iron-dependent, so that Adinolfi et al 
proposed that frataxin function as iron sensor tuning the quantity of Fe-S clusters 
formed to match the concentration of the apo-acceptors (Adinolfi, Iannuzzi et al. 
2009). Frataxin would have low affinity for the IscS-IscU system at normal iron 
levels, but at any even small iron imbalance, the affinity of the protein for IscS would 
increase (Adinolfi, Iannuzzi et al. 2009). Several studies support the role of frataxin 
as regulator of Fe-S cluster biogenesis and disfavour its involvement as an iron 
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3. PRELIMINARY PREPARATION 
The isc operon encodes a complex system and its mechanism involves several 
proteins with different characteristics of structure and stability. Before starting its 
investigation, the preliminary preparation of all the constituents (desulfurase IscS, 
the scaffold protein IscU, the chaperone system of HscA and HscB and ferredoxin) 
was required, meaning their expression, purification and eventual characterization. 
Fortunately they had already been studied in depth in the Pastore lab and all the 
protocols of purification were already available and well optimized. 
 
3.1 Protein purification 
All the genes encoding the Isc proteins had been inserted in pET24 vectors and 
plasmids were already available in the group. They were introduced in BL21(DE3) 
E. coli competent cells by transformation. These cells contain the T7 RNA 
polymerase gene and are under the control of the lacUV5 promoter, so IPTG was 
used to induce the expression. Proteins were expressed with a His-tagged 
glutathione S-transferase (GST) that was separated from the Isc protein by a 
cleavage site for Tobacco Etch Virus (TEV) protease, corresponding to the amino 
acid sequence ENLYFQG where the cleavege is made specifically between the 
glutammine and the glycine. 
 
 
Figure 3.1 Example of a Isc protein sequence expressed with GST,His-tag and the specific TEV 
cleavege site ENLYFQG. 
 
Proteins were purified by affinity chromatography using Ni-nitrilotriacetic (Ni-NTA) 
columns, which interact with the His-tag, washed with two buffers at different salt 
concentration and then eluted with an imidazole solution. The tag of the collected 
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proteins was cleaved by TEV protease. The reaction mixture was passed again 
through a Ni-column to separate the protein from the His-tagged GST. Further 
purification was carried out by size exclusion chromatography on a Superdex 
column. After each step an SDS PAGE was run to check the purity of the 
recombinant protein. The same protocol has been followed for the purification of 
IscS, IscU, HscA, HscB and FdX. In figure 3.2 is reported the SDS PAGE gel run 
during HscB purification as representative. 
 
 
Figure 3.2 SDS PAGE	  run during HscB purification. Each column shows the sample purity after a 
specific step of the purification process. Components are separated by molecular weight. Initially 
proteins were purified on a Ni-NTA column (1. Throughflow the column. 2. First step of wash 3. Second 
step of wash. 4. Step of elution of the fusion protein between HscB (21 kDa) and GST (26 kDa) with a 
300mM imidazole solution). After the overnight cleavage step by TEV protease dialysing in 20 mM 
Tris-HCl pH 8, 150 mM NaCl, spots corresponding to GST and HscB appeared (5) and the sample was 
loaded again on the Ni-NTA column (6. Throughflow the column). The liquid eluted after the cleavage 
still presented His-tagged proteins (7). The process was terminated with a step of FPLC purification on 
a 16/60 Superdex G75 column with 20 mM Tris-HCl pH 8, 150 mM NaCl and 2 mM DTT buffer (8). 
 
Figure 3.3 shows the sample purity obtained at the end of IscS (45kDa), IscU 
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(14kDa), HscA (66kDa) and FdX (12kDa) purification. 
 
 
Figure 3.3 SDS PAGE	  run after the purification of IscS, IscU, HscA and FdX. 
 
3.2 HscB and HscA characterization 
In my work, I focused the attention on the involvement of the two chaperones HscA 
and HscB in the Fe-S cluster enzymatic formation and transfer. Before starting, their 
fold and activity were tested. 
 
3.2.1 CD study of HscB 
Circular dichroism (CD) is usefull in the study of proteins for structural and 
conformational purpose because each type of secondary structur presents a 
characteristic shape in the spectrum. The folding of HscB was thus controlled 
recording its CD spectrum in the range between 195 and 260 nm. 
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BOX 1 Principle of Circular Dichroism of proteins 
Circular Dichroism is the difference in absorption of left and right circularly polarised 
light due to the chirality of molecules.  
€ 
CD = Al − Ar  
The main uses of CD in the study of proteins are for structural or stability purposes, 
since CD contains information about the asymmetric features. Proteins are formed 
by L-amino acid that arrange in chiral secondary structures. CD gives thus 
information about the backbone and CD signal arises from the backbone amide 
transitions in the range of ∼190 to 260 nm. Distinctive CD spectra have been 
described for pure conformations such as α-helix, β-sheets, β-turns and also the 
random coil. CD of a native protein is then the sum of the appropriate percentages 
of each component spectrum.  
The CD spectra of α-helices are characterized by a negative band with two separate 
minima of similar magnitude at 222nm and 208 nm. The α-helix CD is larger in 
magnitude than the one due to other motifs. 
The general characteristics of β-sheet CD may be taken to be a negative band at 
about 216 nm and a positive band of a comparable magnitude near 195 nm.  
The label β-turns is usually used to include all possible turns that occur to enable a 
single strand to become an anti-parallel β-sheet. A typical β-turn CD spectrum has 
been identified with a weak negative band near 225 nm, a strong positive transition 
between 200 and 205 nm and a strong negative band between 180 and 190 nm. 
When we refer to random coils, we are generally grouping the parts of the folded 
protein that do not fit into any one of the previously discussed categories which 
means that there may be ordered structures included in this residual. The CD of 
these parts of the protein has a strong negative CD signal just below 200 nm, a 
positive band at about 218 nm in many systems and perhaps a very weak negative 
band at 235 nm. 
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As it is shown in figure 3.5, HscB CD spectrum presents two bands at around 222 
and 208 nm confirming that it is predominantly a α-helical protein and has an 
ordered and well folded secondary structure (90.5 % α-helix, 0.8% β-strand, 
estimated with K2D3 web server). 
 
 
Figure 3.4 CD spectra of pure secondary structures (Brahms and Brahms 1980). 
 
Protein CD spectra are empirically analyzed by expressing them as a combination 
of standard spectra corresponding to a limited number of well-defined backbone 
geometries. There is a range of different computer programs available for 
determining the percentage of different structural motifs from CD spectrum. All use 
standard reference spectra (Sb1; Sb2…Sbn) with respect to which a measured 
spectrum is decomposed so that the difference between the appropriately weighted 
sum of the reference spectra and the experimental spectrum is minimum (Rodger 
1997). 
€ 
S exp − aiSbi
i
∑ =min∑  
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Figure 3.5 CD spectrum of HscB with a protein concentration of 10 µM in 20 mM Tris-HCl pH 8, 150 
mM NaCl and 2 mM DTT, at room temperature, in cuvettes of 1 cm path length with 0.1 nm of 
resolution, a band width of 2 nm and a scan speed of 200 nm/min and accumulated 30 times. The 
baseline correction was obtained by subtraction of the buffer spectrum. 
 
3.2.2 HscA ATPase activity 
HscA is a constitutively expressed chaperone, belonging to the Hsp70 class. Its 
activity is coupled to ATP binding and hydrolysis with conformational changes that 
control the peptide substrate affinity (Silberg and Vickery 2000). HscA is regulated 
by the scaffold protein IscU and the co-chaperone HscB. IscU behaves as a 
substrate for HscA and HscB enhances the binding of IscU to HscA. Individually, 
HscB and IscU weakly stimulate HscA ATPase activity, but together the stimulation 
is synergistic (Silberg, Tapley et al. 2004). 
I thus checked the ability of freshly purified HscA to hydrolise ATP in the presence 
and absence of HscB and both HscB and IscU. I used an enzyme assay based on a 
procedure originally described by Webb that provides a spectrophotometric method 
for the quantification of inorganic phosphate (Pi) (Webb 1992). In the presence of Pi, 
the substrate 2-amino-6-mercapto-7-methylpurine riboside (MESG) is converted 
enzymatically by purine nucleoside phosphorylase (PNP) to ribose 1-phosphate and 















































Figure 3.6 ATPase activity of HscA. The enzymatic conversion of MESG to ribose 1-phosphate and 
2-amino-6-mercapto-7-methylpurine is accompanied by a change in absorption at 360 nm that allows 
the quantification of inorganic phosphate consumed in the reaction (top). On the bottom it is shown the 
measurement of the ATPase activity. The following reagents were combined: 200 µM of MESG, PNP 
and 150 µM ATP (blue), 150 µM ATP and 1 µM HscA (red), 150 µM ATP, 1 µM HscA and 50 µM HscB 
(green), 150 µM ATP, 1 µM HscA, 50 µM HscB and 50 µM IscU (purple). The substrate ATP was 
added after incubation at 22 °C for 30 minutes and the absorbance at 360 nm was measured. 
 
Curves in figure 3.6 confirm what was already shown by Chandramouli et al. 
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List of reagents 
Reagents and consumables used in the experiment presented in my work were 
ordered from the following companies: 
BL21(DE3) competent cells (Novagen); LB Broth (Fisher Scientific); LB-Agar 
(Sigma); kanamycin (Sigma); IPTG (generon); Igepal (Sigma-Aldrich); Lysozyme 
(Sigma); DNase I (Roche); Complete EDTA-free (Roche); DTT (Sigma-Aldrich); 
TCEP (Sigma); Tris-HCl (Thermo Scientific); NaCl (Fisher Scientific); Imidazole 
(Sigma-Aldrich). 
Ni-NTA affinity resin (Generon); glutathione sepharose 4B (Pharmacie Biotech), 
Dialysis Membrane (Spectrum Laboratories). 
Fe(NH4)2(SO4)2 (Sigma); L-cysteine (Sigma); ATP (Sigma); MgCl2 (Sigma). 
12% Tris-Glycine gel (Novex life technologies); Nu-MES Buffer (Novex life 
technologies); Instant Blue (expedeon). 
Acetic acid (Fisher Chemical); acetonitrile (ROMIL). 
DMA (Thermoscientific); BS3 (Thermoscientific); PBS buffer1 (common buffer 
preparation service at the National Institute for Medical Research); NAP-5 
Sephadex columns (Healthcare). 
M9 salts2 (common buffer preparation service at the National Institute for Medical 
Research); D-(+)-Glucose (Fisher Chemical); (NH4)2SO4 (15N, 99%) (Cambridge 
Isotope Laboratories Inc.); D2O (D, 99.96%) (Cambridge Isotope Laboratories Inc.). 
Agarose (Sigma). 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  PBS composition: 1.37 M NaCl, 27 mM KCL, 100 mM Na2HPO4, 18 mM KH2PO4, pH 7.4	  2	  M9 salts composition: Na2HPO4 6 g/l, KH2PO4 3 g/L, NaCl 0.5 g/L, MgSO4 2 mM, CaCl2 0.1 mM D-
biotin 1 mg/L, thiamine 10 µM, trace elements.	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Protein Purification 
Proteins were individually expressed from pET-derived plasmid vectors as fusion 
proteins with His-tagged glutathione S-transferase (GST) and a cleavage site for 
Tobacco Etch Virus (TEV) protease. They were expressed and purified from E. coli 
strain BL21(DE3) as previously described (Adinolfi, Trifuoggi et al. 2002, Adinolfi, 
Rizzo et al. 2004, Prischi, Pastore et al. 2010). Cells were inoculated at 37 °C in LB 
medium with kanamycin (30 µg/mL) and induced overnight at 18 °C by the addition 
500 µL of 0.5 mM isopropyl β-D-thiogalactopyranoside (IPTG) when the culture 
reached an optical density (OD) at 600 nm of 0.6 - 0.8. Cell pellets were centrifuged 
at 3500 rpm for 25 minutes at 4 °C with a JA-10 rotor. They were resuspended in a 
lysis buffer (20 mM Tris-HCl pH 8, 150 mM NaCl, 10 mM imidazole, 20% v/v Igepal, 
DNAse I, lysozyme, antiprotease, 1 mM TCEP) and frozen. Cell pellets were then 
thawed and sonicated and centrifuged at 18000 rpm for 40 minutes at 4 °C with a 
JA-20 rotor. Proteins were purified by affinity chromatography (using Ni-
nitrilotriacetic agarose), eluted with wash1 (20 mM Tris-HCl pH 8, 150 mM NaCl, 10 
mM Imidazole, 1 mM TCEP), wash2 (20 mM Tris-HCl, pH 8, 1 M NaCl, 10 mM 
Imidazole, 1 mM TCEP) and finally with elution buffer (300 mM Imidazole, 1 mM 
TCEP). They were cleaved overnight from His, GST-tag by TEV protease dialysing 
in 20 mM Tris-HCl pH 8, 150 mM NaCl, 1 mM DTT. Further purification was carried 
out by gel filtration chromatography on a 16/60 Superdex G75 column. Samples 
were eluted in 20 mM Tris-HCl pH 8, 150 mM NaCl and 2 mM DTT and monitoring 
absorbance at 280 nm. Protein concentration was determined by UV spectroscopy 
using the following extinction coefficients derived computationally whit Expasy from 
the sequences (http://web.expasy.org/protparam/): ε280 (IscS)= 41370 M-1cm-1; ε280 
(HscA)= 20400 M-1cm-1; ε280 (HscB)= 16960 M-1cm-1 and ε280 (FdX)= 6990 M-1cm-1. 
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CD spectra 
Far-UV CD spectra were recorded on a Jasco J-815 CD Spectrometer. 
Measurements were repeated at least twice on independent protein preparations to 
ensure reproducibility of the results. Samples were prepared using a HscB 
concentration of 0.15 mg/mL in 20 mM Tris-HCl pH 8, 150 mM NaCl and 2 mM DTT. 
Measurements were carried out at room temperature in fused silica cuvettes of 1 cm 
path length (Hellma). Tipically CD spectra were recorded between 190 and 260 nm, 
accumulated 30 times, with 0.1 nm of resolution, a band width of 2 nm and a scan 
speed of 200 nm/min. A nitrogen flow assured anaerobic conditions and a baseline 
correction was obtained by subtraction of the appropriate buffer spectrum. The web 
server K2D3 (http://cbdm-01.zdv.uni-mainz.de/~andrade/k2d3/) was used to 
estimate the α-helix and β-strand content of the protein from its CD spectrum. 
 
ATPase activity assay 
The ATPase activity of HscA in the presence and absence of HscB or both HscB 
and apo-IscU was assessed at room temperature by measuring the phosphate 
released via a coupled enzyme assay with the EnzChek phosphate assay kit 
(Invitrogen). The reaction mixture was set up with 10 µM HscA; 10 µM HscB and 10 
µM IscU were added when necessary. The substrate, ATP 150 µM, was added after 
10 minutes of incubation and the absorbance at 360 nm was read as a function of 
time. 
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4. BIOCHEMICAL APPROACH 
To understand the mechanism of Fe-S cluster biosynthesis and the role that each 
component of the machinery has in it, I designed an experiment that allowed the 
following of cluster formation in vitro using the E. coli Isc system. The aim was to 
find a way to detect the Fe-S cluster formed through an assay selective and at the 
same time easy to perform and reproducible. 
 
4.1 The kinetic assay 
It was already well described that Fe-S cluster can be formed in vitro in the 
presence of IscS, that behaves as a source of sulfur converting cysteine into 
alanine, the scaffold protein IscU, Fe2+ and a reducing agent. It was essential to 
completely remove the oxygen from the system to avoid the oxidation of iron and 
thus to perform the assay under an inert atmosphere of nitrogen (Adinolfi, Iannuzzi 
et al. 2009). The Fe-S cluster was then transferred from the scaffold to an apo-
protein and detected by a spectrophotometric technique. Enzymatic rates were 
determined by detecting the absorbance of the reporter acceptor as a function of 
time. All proteins able to accept the Fe-S cluster present a specific wavelength of 
absorbance in the UV-Vis range when they are bound to the cluster and they can 
thus be used as reporter for this assay. Among them are ferredoxin, aconitase2 and 
IscU.  
Ferredoxin is known to be able to bind Fe-S cluster and its holo-form shows a 
characteristic absorbance at 458 nm (Yan, Adinolfi et al. 2013). It means that when 
it receives a Fe-S cluster, an increase in the absorbance at this wavelegth could be 
observed (figure 4.1).  
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Figure 4.1 UV-Vis spectrum of apo-ferredoxin (dashed line) and [2Fe-2S]-ferredoxin (solid line) 
with a protein concentration of 10 µM in 20mM Tris-HCl pH 8, 150 mM NaCl and 2 mM DTT. A 
baseline correction was obtained by subtraction of the buffer spectrum. 
 
Aconitase2 is one of the most common Fe-S proteins. I proved its ability to accept 
Fe-S clusters synthetised and released in the presence of the desulfurase IscS and 
of the scaffold IscU. I mixed under strictly anaerobic conditions the desulfurase IscS, 
the scaffold IscU, the substrates Fe2+ and cysteine with aconitase2 and the variation 
in absorbance between 240 and 800 nm was monitored every 2 minutes. A 
characteristic spectrum was recorded with specific absorbance peaks at 490, 450, 
406 and 315 nm (figure 4.2). A major change in the intensity was observed for the 
peak at 406 nm. Plotting the absorbance value at this wavelength against the time, 
the kinetic curve of the Fe-S cluster synthesis and transfer to the aconitase2 was 
obtained (figure 4.3). The reaction reached a plateau very quickly and the variation 
in absorbance appeared pronounced. Aconitase2 seems to be a good acceptor of 
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Figure 4.2 UV-Vis spactra of aconitase2 reconstitution (30 µM) measured in presence of 1 µM 
IscS, 5 µM IscU, 3 mM DTT after 0, 4, 10, 20, 30 and 40 minutes from the addition of substrates 250 
µM Cys and 75 µM Fe2+ in 20 mM Tris-HCl pH 8, 150 mM NaCl. 
 
 
Figure 4.3 Kinetic of aconitase2 reconstitution. Absorbance at 406 nm against the time in the 
reconstitution of 30 µM Aco2 in the presence of 1 µM IscS, 5 µM IscU, 3 mM DTT, 250 µM Cys and 75 
µM Fe2+ in 20 mM Tris-HCl pH 8, 150 mM NaCl. 
 
The use of IscU is a special case because IscU is itself the scaffold protein and in 
this case the step of transfer is absent. When the cluster is formed on it, the 
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Figure 4.4 Kinetic curves of formation of Fe-S cluster on IscU. Absorbance at 456 nm against the 
time in the reconstitution of 30 µM IscU in presence of 1 µM IscS and 3 mM DTT with 250 µM Cys and 
25 µM Fe2+ in 20 mM Tris-HCl pH 8, 150 mM NaCl. 
 
In practice the assay consisted in adding Fe2+ and DTT in a cuvette containing the 
Isc proteins under inert atmosphere of nitrogen to avoid oxidation. The cluster was 
formed enzymatically by IscS and IscU and in the eventual presence of other 
proteins as chaperones HscA and HscB. Chaperones are thought to assist the step 
of transfer and, if this was the rate limiting step, in their presence I would expect an 
increase in the activity of Fe-S cluster constitution. Since HscA shows and ATPase 
activity fundamental for the system, ATP was added as well. After 30 minutes, when 
the system was equilibrated, cysteine and ATP were added to start the reaction. Fe-
S cluster formation and its transfer to an acceptor were then easily followed by 
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4.2 Optimization of IscU, HscA, HscB and ATP 
concentrations 
Because I worked with a complex multi-component system, I first optimized the 
relative concentrations of the components. The concentration of apo-ferredoxin, 
which I chose as final cluster acceptor in the assay, was set to 50 µM to easily 
measure the signal of the cluster. IscS was set to catalytic concentrations (1 µM) to 
avoid even minimal contributions of unspecific iron-thiolate polysulphides bound to 
IscS (Bonomi, Pagani et al. 1985). The presence of reductant DTT was necessary 
to provide reducing equivalent required for cluster generation and to regenerate the 
prosthetic group pyridoxal phospate (Urbina, Silberg et al. 2001). I started using 1 
µM IscU, 1 µM HscA, 1 µM HscB and 3 mM DTT with 250 µM Cys, 150 µM ATP 
and 25 µM Fe2+ as basic condition. For each experiment, the variation of the 
absorbance at 458 nm against time was reported.  
Although some curves showed a delay, which probably reflects diffusion of the 
components, the slope of the kinetic curves (absorbance versus time) was 
measured after the detention time to quantitatively compare the reaction rate. The 
plot of these values against the protein concentration allowed me to determine the 
change on the activity of the Fe-S cluster formation.  
 
Increasing IscU concentrations (1, 5, 10, and 20 µM) enhanced the reconstitution 
rate and shortened the lag phase, reaching a plateau above 5 - 10 µM (figure 4.5). 
To ensure the higher activity and, at the same time, avoid the contribution to the 
absorbance due to Fe-S cluster binded to IscU, I thus adopted 8µM concentrations 
of IscU in the following experiments. 
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Figure 4.5 (A) Scan of the IscU concentration. Absorbance at 458 nm against the time in the cluster 
formation on 50 µM Fdx in the presence of 1 µM IscS, 1 µM HscA, 1 µM HscB, 3 mM DTT, 250 µM 
Cys, 150 µM ATP, 25 µM Fe2+ and 10 mM Mg2+ in 20 mM Tris-HCl pH 8, 150 mM NaCl. IscU was 
varied from 1 µM (green) to 5 µM (violet), 10 µM (cyan), 20 µM (orange). 
 
Figure 4.5 (B) Scan of the IscU concentration. Corresponding rates estimated from the slope of the 
initial part of the curves after the lag time. 
 
A progressive increase of the HscB concentration caused a clear reduction in the 
reaction rate and in addition the delay was extended (figure 4.6). A 3 µM HscB 
concentration was adopted in the following experiments to ensure a small excess of 
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Figure 4.6 (A) Scan of the HscB concentration. Absorbance at 458 nm against the time in the 
cluster formation on 50 µM Fdx. The concentrations of IscU and HscA were fixed to 8 µM and 1 µM. 
The other components were as above. HscB was varied from 0 µM (blue) to 5 µM (violet), 10 µM 
(cyan), 15 µM (orange), 20 µM (pale blue) and 30 µM (red). 
 
Figure 4.6 (B) Scan of the HscB concentration. Corresponding rates estimated from the slope of the 
initial part of the curves after the lag time. 
 
Variation of the HscA concentration in the range 1 - 5 µM led to no change of the 
cluster formation rates. Above ∼5 µM, I observed a deep decrease of the rates 
(figure 4.7). A 2 µM concentration was thus adopted in the following measurement 
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Figure 4.7 (A) Scan of the HscA concentration. Absorbance at 458 nm against the time in the 
cluster formation on 50 µM Fdx. The concentrations of IscU and HscB were fixed at 8 µM and 3 µM. 
HscA was varied from 0 µM (violet) to 1 µM (pale blue), 5 µM (green), 10 µM (violet), 15 µM (orange), 
20 µM (cyan) and 30 µM (red). The other components were as in the previous experiment. 
 
Figure 4.7 (B) Scan of the HscA concentration. Corresponding rates estimated from the slope of the 
initial part of the curves after the lag time. 
 
Finally, I screened the effect of ATP varying it from 0 to 1 mM in the absence and in 
the presence of 10 mM Mg2+. When no Mg2+ was added I observed a dramatic 
reduction of the rates up to almost complete inhibition of the reaction (figure 4.8 (A)). 
The effect was drastically reduced and practically abolished at 10 mM Mg2+ which 
are the concentrations typically used for this assay because close to the cellular 





























































	   61	  
 
Figure 4.8 (A) Scan of the ATP concentration in the absence of Mg2+. Absorbance at 458 nm was 
plotted against the time in the cluster formation on 50 µM Fdx. IscS, IscU, HscA and HscB were fixed 
at 1 µM, 8 µM, 2 µM and 3 µM respectively in 20 mM Tris-HCl pH 8, 150 mM NaCl, 3 mM DTT, 250 µM 
Cys and 25 µM Fe2+. ATP was varied from 0 µM (green) to 150 µM (blue), 250 µM (violet), 500 µM 
(red) and 1 mM (cyan). 
 
Figure 4.8 (B) Scan of the ATP concentration in the presence of 10 mM Mg2+. Absorbance at 458 
nm was plotted against the time in the cluster formation on 50 µM Fdx. IscS, IscU, HscA and HscB 
were fixed at 1 µM, 8 µM, 2 µM and 3 µM respectively in 20 mM Tris-HCl pH 8, 150 mM NaCl, 3 mM 
DTT, 250 µM Cys and 25 µM Fe2+. ATP was varied from 0 µM (green) to 150 µM (blue), 250 µM 
(violet), 500 µM (red) and 1 mM (cyan). 
 
These results showed the effects of the most important Isc components in the 
kinetics of Fe-S cluster biosynthesis: the increase of IscU concentrations facilitates 
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contrary, the increase of HscA and HscB amounts slows down the process. These 
results reproduced a previous study that was however carried out mainly in the 
absence of IscS (Iametti, Barbiroli et al. 2015). ATP content in the presence of Mg2+ 
does not influence the reaction rate, however it has a strong decreasing effect in its 
absence. A plausible way to explain this is that ATP is well known to chelate iron 
(Mansour, Thompson et al. 1985, Patchornik, Goldshleger et al. 2000). It would then 
result in depletion of Fe2+ from solution. Mg2+, the counter ion always used with 
chaperones with ATPase activity, is thus particularly important to compete with Fe2+ 
binding. 
 
4.3 Dissecting the effects on enzymatic activity 
I repeated the kinetic experiments of Fe-S cluster formation, exploring the effects of 
each component to understand the factors for which HscA and HscB behave as 
inhibitors. I introduced them individually and in pair in the absence and in the 
presence of 150 µM ATP. I used again Fdx as the reporter, 1 µM of IscS and 8 µM 
of IscU, in the presence of 250 µM Cys, 25 µM Fe2+ and 10 mM Mg2+.  
 
 
Figure 4.9 Effect of the individual components in the absence of ATP. Absorbance at 458 nm was 
plotted against the time in the cluster formation on 50 µM Fdx in the presence of 1 µM IscS and 8 µM 
IscU (control, orange), 10 µM HscA (red), 10 µM HscB (green), 10 µM HscA/HscB (violet) in 20 mM 
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Figure 4.10 Effect of the individual components in the presence of ATP. Absorbance at 458 nm 
was plotted against the time in the cluster formation on 50 µM Fdx in the presence of 1 µM IscS and 8 
µM IscU (control, orange), 150 µM ATP (blue) and with 10 µM HscA (red), 10 µM HscB (green), 10 
µM HscA/HscB (violet) in 20 mM Tris-HCl pH 8, 150 mM NaCl, 3 mM DTT, 250 µM Cys, 25 µM Fe2+ 
150 µM ATP and 10 mM Mg2+. 
 
In the absence of ATP, introduction of HscA (10 µM) does not produce appreciable 
effects on the enzymatic rates. Addition of HscB (10 µM) remarkably inhibits the 
rates, while co-addition of HscA and HscB produces a further drop (figure 4.9). In 
the presence of ATP, addition of HscA increases the rates in a comparable way 
than when adding only ATP. Addition of HscB, alone or together with HscA and ATP 
appreciably reduces the rates (figure 4.10). This tells that the effect is mainly due to 
HscB, either in the presence or absence of HscA. 
 
The effect of HscA appears to be complex and is further complicated by the 
presence of ATP. I decided to focus on the investigation of the causes of the 
inhibition effect of HscB. I first repeated the screening of HscB concentrations, but 

























	   64	  
 
Figure 4.11 (A) Time course of cluster formation on Fdx (50 µM) in the presence of 1 µM IscS, 8 
µM IscU, 3mM DTT with 250 µM Cys and 25 µM Fe2+ and increasing concentrations of HscB. The 
curves correspond to no HscB (blue), 3 µM (violet), 5 µM (red), 8 µM (pale blue), 10 µM (green), 20 µM 
(cyan) and 40 µM (orange) in 20 mM Tris-HCl pH 8, 150 mM NaCl. 
 
Figure 4.11 (B) Time course of cluster formation on Fdx. Corresponding rates estimated from the 
slope of the initial part of the curves after the lag time. 
 
I observed a clear progressive drop of the rates. Plotting the slope of the curves 
versus the concentration I obtained a rate decrease, which reaches a plateau 
between 20 - 40 µM (figure 4.11). I wondered if the effect could be consequence of 
the protein reporter used given that Fdx is somewhat a special case because itself 
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2013). I thus repeated the measurements using aconitase2 (figure 4.12) (Beinert, 
Kennedy et al. 1996) or IscU (figure 4.13) as reporter (35 µM).  
 
 
Figure 4.12 (A) Kinetics of cluster formation on aconitase2 (35 µM) in the presence of 1 µM IscS, 8 
µM IscU, 3mM DTT with 250 µM Cys, 25 µM Fe2+ and increasing concentrations of HscB. The curves 
correspond to no HscB (blue) and HscB 1 µM (violet), 5µM (red), 10 µM (green), 15 µM (pale blue), 20 
µM (cyan) and 40 µM (orange) in 20 mM Tris-HCl pH 8, 150 mM NaCl. 
 
Figure 4.12 (B) Kinetics of cluster formation on aconitase2. Corresponding rates estimated from 
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Figure 4.13 (A) Kinetics of cluster formation on IscU (35 µM) in the presence of 1 µM IscS, 3mM 
DTT with 250 µM Cys, and 25 µM Fe2+ and increasing concentrations of HscB. The curves correspond 
to no HscB (blue), HscB 5 µM (violet), 10 µM (red), 20 µM (green), 25 µM (pale blue), 30 µM (cyan) 
and 40 µM (orange) in 20 mM Tris-HCl pH 8, 150 mM NaCl. 
 
Figure 4.13 (B) Kinetics of cluster formation on IscU. Corresponding rates estimated from the slope 
of the initial part of the curves after the lag time. 
 
Addition of HscB decreases both rates as in the previous case. The effect is thus 
due to HscB specifically and it is independent from the reporter. 
 
4.4 Discussion 
In the last fifteen years, increasing efforts have been dedicated to understand the 
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the role of each of the players and understand the chemistry which drives cluster 
synthesis. A main difficulty in analysing the machine in vitro is, however, the 
complexity of the multi-component system in which each protein can further be in 
several possible states (oxidized/reduced, cluster-loaded/cluster-free, etc.). The 
additional presence of iron cations, nucleotides (as ATP) and cysteine further 
complicate the picture. This increases the number of possible interactions 
combinatorially. 
Probably for this reason, there are still relatively few studies that address the role of 
HscB and HscA in the Isc machine. Chandramouli and Johnson showed that HscA 
and HscB from A. vinelandii stimulate [2Fe-2S] cluster transfer from IscU to apo-Fdx 
in an ATP-dependent reaction (Chandramouli and Johnson 2006). These 
researchers, however, probed only the second step of the reaction recording 
formation of the cluster on Fdx in the absence of the desulfurase. More recently, a 
study of the role of HscB and HscA from E. coli was carried out by Iametti who 
showed that HscA/HscB/ATP system has an inhibitory effect when the cluster is 
formed on IscU and independently from the source of sulfur (chemical or enzymatic) 
(Iametti, Barbiroli et al. 2015). They also used Fdx as the reporter for chemical 
cluster formation and observed an enhancement. The effect was explained by the 
well described interaction between IscU and the chaperones (Hoff, Silberg et al. 
2000, Fuzery, Tonelli et al. 2008). 
I started my study with the purpose of investigating the effect further. I first explored 
the multidimensional space of the Isc interactome keeping the minimal number of 
components (IscA and IscR are thought to enter in the picture as independent 
players) and optimising the relative concentrations within ranges of concentration 
biologically reasonable. Comparing the initial reaction rates, it was observed that in 
the presence of HscA and HscB the activity decreases.  
To put more efforts to better understand the role of the chaperones in the Fe-S 
cluster, I introduced the components individually to identify their contributions. I 
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observed that HscB, alone and in the co-presence of HscA, could have detrimental 
effects on the rate of cluster formation depending on their range of concentrations. 
This is at strong variance with what could have been expected for chaperones 
intended as “helper of folding” (Silberg and Vickery 2000, Silberg, Tapley et al. 
2004). 
I then focused on the investigation of the effect of the co-chaperone HscB only. It 
can be noted that ferredoxin, the protein used as reporter, could be involved itself in 
the Fe-S cluster biosynthesis since it is encoded by the isc operon (Yan, Adinolfi et 
al. 2013, Yan, Konarev et al. 2013). For these reasons, I looked at HscB influence 
when Fe-S cluster is formed directly on the scaffold protein IscU or after it is 
transferred to Aco2. The inhibitor effect of HscB was thus confirmed to be 
independent from the reporter used. 
 
4.5 Methods 
Ferredoxin UV-Vis spectrum 
UV-Vis spectra of 10 µM apo and holo-FdX in 20mM Tris-HCl pH 8, 150 mM NaCl 
and 2 mM DTT were recorded using a Cary 50 Bio Spectrophotometer (Varian) in 
the range between 240 and 750 nm. A baseline correction was obtained by 
subtraction of the appropriate buffer spectrum. 
 
Aconitase2 reconstitution experiments  
Cluster reconstitution was performed under strict anaerobic conditions in a Belle 
chamber kept under nitrogen atmosphere. The reaction was followed by absorbance 
spectroscopy using a Cary 50 Bio Spectrophotometer (Varian). Absorbance 
between 240 and 800 nm were recorded every 2 minutes. A solution of 30 µM of 
Aconitase2 was incubated in sealed cuvettes typically using 3 mM DTT, 5 µM IscU, 
1 µM IscS and 75 µM Fe(NH4)2(SO4)2 for 30 minutes in 20 mM Tris-HCl pH 8 and 
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Enzymatic cluster formation was achieved under strict anaerobic conditions in a 
Belle chamber kept under nitrogen atmosphere. The reaction was followed by 
absorbance spectroscopy using a Cary 50 Bio Spectrophotometer (Varian). 
Absorbance variations at 458 nm or 406 nm or 456 nm were measured as a function 
of time. A solution of 50 µM of apo-Fdx (or 35 µM aconitase2 or 35 µM IscU, 
depending on the reporter used) was incubated in sealed cuvettes typically using 3 
mM DTT, IscU, HscA, HscB, 1 µM IscS and 25 µM Fe(NH4)2(SO4)2 for 30 minutes in 
20 mM Tris-HCl pH 8, 150 mM NaCl and 10 mM MgCl2. The reaction was initiated 
by adding 250 µM of the substrate L-cysteine and when specified 150 µM ATP. 
Each experiment was repeated at least 3 times on different batches of proteins. To 
simplify the analysis, I took the initial slopes of the curves (absorbance versus time) 
to qualitatively compare the time courses.  
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5. BIOPHYSICAL APPROACH  
Investigation of Fe-S cluster enzymatic constitution made by desulfurase IscS and 
the scaffold protein IscU, showed that the presence of the chaperones HscA and 
HscB, and in particular the co-chaperone HscB, unexpectedly decreases the initial 
reaction rate. This is at variance with the hypothesis that they assist the step of 
cluster transfer causing an increase of the system activity (Chandramouli and 
Johnson 2006). A reasonable working hypothesis to explain this observation was 
that one of them could bind the desulfurase IscS interfering with the first step of the 
cluster biogenesis. 
 
5.1 Effect of HscB on the desulfurase activity 
In the reconstitution assay it was not possible to distinguish between the two steps 
of Fe-S cluster formation and cluster transfer to the acceptor. Several studies have 
been performed by Bonomi and collaborators to explore the transfer of the Fe-S 
cluster from holo-IscU to an acceptor in the presence of chaperones (Chandramouli 
and Johnson 2006, Bonomi, Iametti et al. 2008) and cluster formation on IscU 
(Iametti, Barbiroli et al. 2015), but the cysteine desulfuration has never been 
investigated. 
 
To establish if HscB has also an inhibitory effect at the desulfuration step, I turned to 
Mass Spectrometry. This technique allows the determination of the amount of 
molecules of a specific molecular weight in the sample. I measured the amount of 
cysteine and alanine, respectively the substrate and product of the IscS activity. It 
allowed me to follow the rates of desulfuration. 
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I designed an experiment with the purpose of measuring the desulfurase activity of 
IscS by detecting the progressive disappearance of cysteine and concomitant 
appearance of alanine. The assay was carried out in the absence of IscU. I 
prepared samples containing 1 µM IscS and 3 mM DTT in 20 mM Tris-HCl pH8 and 
150 mM NaCl. Once the reaction was initiated by adding 250 µM of cysteine, a 
mixture of acetic acid/acetonitrile was used to stop it at different time points (0, 10, 
20, 40, 60 min). This agent precipitates and denatures proteins. The experiment 
BOX 2 Principle of Mass Spectrometry 
Electrically charged particles are affected by a magnetic field while electrically 
neutral ones aren’t. In Electronspray Mass Spectrometry, proteins and peptides are  
positively ionised by adding protons. Ions are accelerated so that they all have the 
same kinetic energy (and speed, v). Their formation and manipulation must be 
conducted in a vacuum because ions are very reactive and short-lived. They are 
then deflected by a magnetic field (B) according to their masses (m). The lighter 
they are, the more they are deflected. The amount of deflection (r) also depends on 
the number of positive charges (z) on the ion. The more the ion is charged, the 
more it gets deflected. These two factors are combined into the mass/charge ratio 
(m/z). 
€ 
r = mz ⋅
v
B  
The beam of ions passing through the machine is detected electrically: when an ion 
hits the metal box, its charge is neutralised by an electron jumping from the metal 
on to the ion. That causes a flow of electrons which is detected as an electric 
current. The more ions arriving, the greater is the current. By varying the strength of 
the magnetic field B, ions of different mass can be focused progressively on the 
detector. The machine can be calibrated to record current against m/z directly.	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was then repeated in the presence of 3 µM of HscB. The samples were then given 
to the Mass Spectrometry facility at King’s College London for the determiation of 




Figure 5.1 Quantification by MS of Cysteine consumption by IscS (1 µM) in 20 mM Tris-HCl at pH 
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Figure 5.2 Quantification by MS of Alanine production by IscS (1 µM) in 20 mM Tris-HCl at pH 8, 
150 mM NaCl and 3mM DTT (top) and in the presence of 3 µM HscB (bottom). 
 
Comparison showed a lower consumption of cysteine in the presence of co-
chaperone HscB (figure 5.1) that results in a lower formation of alanine (figure 5.2). I 
concluded that the reaction is slowed down. 
Altogether, this result with the previous biochemical investigation (see chapter 4) tell 
that the inhibitory effect is mainly linked to HscB but it is not only due to the 
interaction between IscU and HscB as previously suggested by Iametti (Hoff, Silberg 
et al. 2000, Iametti, Barbiroli et al. 2015): HscB has also effects on the desulfurase 
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5.2 HscB interacts with IscS 
A reason why HscB could affect the enzymatic activity of IscS is the formation of a 
complex between the two proteins. This hypothesis is reasonable not only if a 
binding is proved but also if HscB binds on a surface important for the progress of 
IscS activity. 
I thus carried out several assays to test the binding and find the surface involved. 
 
5.2.1 Pull-down assays 





His-tag and GST-tag are suitable tags for this kind of assay because the His-tag 
allows proteins to bind specifically the Ni-NTA resin and the GST-tag allows the 
binding to glutathione sepharose resin. 
BOX 3 Principle of pull-down assay 
A pull-down assay is a small-scale affinity purification technique. A bait protein is 
tagged and immobilized on a surface by affinity ligand specific for the tag. It 
generates a secondary affinity support for the purification of other proteins (prey 
proteins) that bind with the bait protein. Proteins are then together eluted depending 
on the affinity of primary ligand and revealed by SDS-Page.  
	  
Figure 5.3 Schematic representation of a pull-down assay.  
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First IscS was chosen as the bait protein: it was expressed and purified in a His-
tagged form. It was incubated for 30 minutes with the partner HscB in a ratio of 1:10 
and then passed on Ni-NTA resin equilibrated with 20 mM Tris-HCl pH 8, 150 mM 
NaCl and 2 mM DTT. The same assay was carried out with the reverse combination 
of bait/prey protein. HscB was expressed and purified with a His,GST-tag, incubated 
half an hour with untagged IscS in a ratio of 1:10 and loaded on a glutathione 
sepharose resin. After extensive washing with the same buffer, supernatant and 




Figure 5.4 SDS PAGE after pull-down assays. Each column shows the sample purity components 
separated by molecular weight. 1. His-IscS+IscU (1:10) supernatant. 2. His-IscS+IscU (1:10) Ni-NTA 
resin. 3. HscB supernatant. 4. HscB Ni-NTA resin. 5. His-IscS+HscB (1:10) supernatant. 6. His-
IscS+HscB (1:10) Ni-NTA resin. 7. GST+IscS supernatant. 8. GST+IscS Glutathione Sepharose resin. 
9. IscS supernatant. 10. IscS Glutathione Sepharose resin. 11. His,GST-HscB+IscS (1:10) 
supernatant. 12. His,GST-HscB+IscS (1:10) Glutathione Sepharose resin. 
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The PAGE gel in figure 5.4 distinguishes protein in accordance with their molecular 
weight. On the left side of the marker were loaded the samples flowed (odd 
numbers) or captured on Ni-NTA resin (even numbers), on the right side samples 
flowed (odd numbers) or captured on Glutathione Sepharose resin (even numbers). 
To test the effectiveness of the procedure, the assay was carried out with a mixture 
of His-IscS and IscU, whose interaction is already well characterized in the literature 
(Urbina, Silberg et al. 2001, Kato, Mihara et al. 2002). IscU was captured by His-
IscS on the Ni-NTA resin (sample 2) and the excess was discarded in the 
supernatant (sample 1). Samples 3 and 4 were run as a control to ensure that HscB 
does not bind the Ni-NTA column in the absence of the tag. A weak affinity was 
observed (sample 4). Then the binding between His-IscS and HscB was tested. The 
prey protein HscB was found in the supernatant (sample 5) without binding the bait 
protein significantly (sample 6). Analogous results were obtained with His,GST-
HscB and IscS on Glutathione Sepharose resin (samples 11 and 12). Samples 7 
and 8 showed a small affinity of IscS for GST protein. Samples 9 and 10 showed 
that the prey protein IscS has a small affinity also for the Glutathione Sepharose 
resin.  
The pull-down assay results to be ineffective to determine binding with low affinity 
as it could be supposed for IscS and HscB.  
 
5.2.2 Size Exclusion Chromatography 
Size Exclusion Chromatography (SEC) is applied to separate a wide range of 
molecules according to size. It is helpful to determine the molecular weight and 
analyse aggregates and complex formation. A mixture made by HscB and IscS was 
passed on a SEC column to determine the formation of their complex. 
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A Superdex 200 HR 10/30 column was chosen because it gives an excellent 
resolution of proteins and peptides in the molecular weight range of 10 and 600 
kDa. In principle, it is able to discriminate between IscS (dimer of 90 kDa), HscB (21 
kDa) and their complex of around 130 kDa.  
 
 
Figure 5.5 SEC chromatogram. Absorbance at 280nm of the 120 µM HscB sample during SEC 
course (blue), 140 µM IscS (red) and the mixture 1:2 of IscS:HscB (yellow) in 20 mM Tris-HCl pH 8, 











































BOX 4 Principle of Size Exclusion Chromatography 
Size Exclusion Chromatography is a chromatographic method in which molecules 
are separated by their size. The column used is filled with material containing many 
pores. When molecules of various sizes flow into the column, smaller molecules 
flow more slowly through the column because they penetrate deep into pores, 
whereas large molecules flow quickly because they do not enter the pores. 
Consequently larger molecules elute from the column sooner and smaller later. 
Proteins are usually separated by gel filtration chromatography, which uses a 
hydrophilic packing material and an aqueous mobile phase. 	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The desulfurase IscS (140 µM), the co-chaperone HscB (120 µM) and then a 
mixture of them (IscS:HscB 1:2), were loaded on the column and eluted with a 20 
mM Tris-HCl pH8, 150 mM NaCl and 2 mM DTT buffer. A SDS PAGE gel confirmed 
the purity of proteins in the fractions. While IscS seemed to be present mostly as a 
dimer but also as a bigger aggregate (maybe as tetramer) and as monomer, HscB 
appeared as a single peak. The mixture of the two proteins showed a curve that 
corresponds exactly to the superimposition of the two single contributes and no 
other peak corresponding at higher molecular weight appeared (figure 5.5). This 
result suggests that the complex is not enough stable and is disassembled through 
the resin.  
 
5.2.3 Crosslinking 
After the above experiments, I became convinced that if there was an interaction 
between IscS and HscB, it was too weak because the complex could survive and be 
detected with methods of protein separation. I attempted thus the chemical 
crosslinking which is a technique able to capture weak or transient protein-protein 
interactions (Watson, Mahajan et al. 2012). 
 
 
BOX 5 Principle of crosslinking 
Crosslinking is the process of chemically joining two or more molecules by a 
covalent bond. Crosslinkers are used for the identification of near-neighbor protein 
relationships as well as ligand-receptor interactions.  
Crosslinking reagents could have spacer arm of different length and they contain 
ends reactive to specific functional groups, such as primary amines and sulfhydryls. 
Homobifunctional, amine-reactive NHS esters or imidates, and heterobifunctional, 
amine-reactive photoactivable phenyl azides are the most commonly used 
crosslinkers for these applications. Sometimes can be used reversibles crosslinkers  




To identify the interaction, I tested two homobifunctional amine-to-amine 
crosslinkers that use imidoester and N-hydroxysuccinimide ester (NHS-ester) 
reactive groups for selective conjugation of primary amines: Dimethyl adipimidate 
(DMA) and Bis[sulfosuccinimidyl]suberate (BS3). 
 
 
Figure 5.6 Crosslinkers structure of DMA and BS3. 
 
DMA is a water soluble homobifunctional imidoester crosslinker. The imidoester 
functional group is one of the most specific acylating group available for the 
modification of primary amines and has minimal cross reactivity toward other 
nucleophilic groups in proteins. It obviously means that in the assay, buffers amine-
containing (such as Tris-HCl) must be avoided. Proteins have primary amines in the 
side chain of lysine residues and in the N-terminus of each polypeptide that are 
available as targets. DMA reacts with amines at pH 7 - 10 and its reaction is 
reversible at high pH values. It has a spacer arm length of 8.6 Å. 
BS3 is a water-soluble and non-cleavable crosslinker. It has an 8-carbon spacer arm 
of 11.4 Å that contains an N-hydroxysuccinimide ester at each end. NHS esters 
react efficiently with primary amino groups (-NH2) in pH 7 to 9 buffers to form a 
D ^Ϲ
with a disulfide bond in the spacer arm that can be easily reduced with DTT.  
The availability of several chemical groups in proteins and peptides make them 
favourable targets for conjugation using crosslinking methods.  
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stable amide bond. Buffers must not contain primary amines. Thus phosphate, 
borate, carbonate and HEPES are useful. The reaction results in the release of N-
hydroxysuccinimide. 
Before starting with the crosslinking assay, the buffer had to be exchanged from 20 
mM Tris-HCl pH 8, 150 mM NaCl, 2 mM DTT to PBS with NAP-5 Sephadex 
columns. I then added the crosslinking agent in excess (1.3 mM) to a mixture 
containing HscB (30 µM) and IscS (5 µM). After 30 minutes the reaction was 
quenched with 20 mM Tris-HCl. 
 
 
Figure 5.7 SDS PAGE after crosslinking assay. Each column shows the sample purity components 
separated by molecular weight. IscS (5 µM), HscB (5 µM) and IscS:HscB (1:6) mixture in the presence 
of crosslinker DMA 1.3 mM (left) or BS3 1.3 mM (right) in PBS buffer. 
 
SDS PAGE on figure 5.7 revealed the species present in the samples by separating 
them as a function of their molecular weight. In the mixture containing HscB and 
IscS with DMA no other band in addition to the free proteins appeared. On the 
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contrary, the presence of a new species at around 65 kDa, which corresponds to 
HscB-IscS covalently bound, was revealed in the sample with BS3. Other bands can 
be observed at higher molecular weight that correspond to IscS dimer (and possibly 
trimer and tetramer, as observed in the control containing IscS alone) and the IscS-
HscB dimer. While DMA has not a spacer arm sufficiently long, BS3 is able to join 
together HscB and IscS. This proved that the two proteins could weakly bind each 
other. 
 
5.2.4 NMR-T1 relaxation measurement 
The observation of a crosslinked band at the expected mass for the HscB-IscS 
complex is a good evidence, but the interaction had to be confirmed with an 
independent and complementary method. I used the nuclear magnetic resonance 




BOX 6 Principle of NMR and time of relaxation 
Nuclear Magnetic Resonance uses the difference of energy of nuclear spin 
  
€ 
ΔE = γ!B0  that arises in the presence of a magnetic field B0. This corresponds to 




2π , where γ is the gyromagnetic ratio, 
an intrinsic and specific property of the nucleus. Spins align along B0 and the 
resultant magnetisation M0 starts a precessional orbit around it. When a radio 
frequency (RF) pulse is applied, it causes another simultaneous precessional 
movement of the magnetization along the direction of this second magnetic field, B. 
The signal is recorded as energy emitted after the RF pulse as function of time (free 
induction decay, FID) and then it is Fourier transformed to give a plot as function of 
frequency.  
In NMR the relaxation is the phenomenon by which the system returns to  
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equilibrium after the impulse and the magnetisation comes back along the direction 
of B0. There are several phenomena of relaxation. The most important are the spin-
lattice relaxation (T1) and the spin-spin relaxation (T2). The relaxation is induced by 
field fluctuation due to molecular motion and local field experienced when the 
molecule reorients. 
The spin-lattice relaxation is the process that returns the magnetization to the B0 
direction (Z-axis). This process can be measured with inversion recovery 
experiment. 
 
Figure 5.8 Inversion recovery schematization. The magnetization is first inverted before the 
acquisition. After a delay a second pulse is applied and the signal is rcorded. 
 
In the inversion recovery pulse sequence, a 180°x pulse is first applied. This rotates 
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spin-lattice relaxation and returns towards its equilibrium position along the +Z axis. 
Before it reaches equilibrium, a 90°x pulse is applied which rotates the longitudinal 
magnetization into the XY plane. Once the magnetization is present in the XY plane, 
it rotates about the Z axis and dephases giving a FID. The equation that describes 
this phenomenon is 
 
T1 relaxation is caused by transient magnetic fields (usually due to molecular 
motions) at the Larmour precession frequency, so relaxation is optimal if the 
average rate of molecular reorientation in space is at this frequency. For small 
molecules at room temperature the average rates of molecular rotation are several 
orders of magnitude higher leading to very inefficient relaxation (long T1). For bigger 
molecules motions become slower and more efficient relaxation results (short T1).  
However, at some point the average molecular motions become so slower than 
Larmour precession frequency that T1 becomes longer again. 
 
 
Figure 5.9 Behaviour of T1 and T2 as a function of the correlation time, τC, the time it takes the 
average molecule to rotate one radian (Purcell 1948). 
€ 
Mz = M0(1− e−t /T1)




Molecular motions induce a magnetic field fluctuation and affect the relaxation 
times. These are affected also by system dimensions because larger proteins show 
overall slower molecular motions. 
NMR experiments were carried out to determine T1 relaxation time of free HscB 15N 
labelled (160 µM). The spectrum was recorded with an inversion recovery sequence 
and using delays (τ) of 10, 100, 200, 400, 700, 1000, 1500, 2000 and 2500 ms. The 
same was repeated for the complex formed by 15N-HscB:IscS (1:0.6). For every 
residue the T1 relaxation time was calculated by fitting the intensity of the peak 
against the time (τ). Only residues with a weighted root mean square (wrms) 




After a pulse, the magnetization becomes coherent in phase in the XY plane. 
However, each spin undergoes to a different magnetic field and rotates with its own 
Larmor frequency. This causes a loose of phase coherence of the magnetization. 
With time the difference of phase increase. This relaxation phenomenon is called 
Spin-Spin relaxation. This process can be measured with the Spin-Echo 
experiment. The spin-spin relaxation is described by the equation 
 
While the longitudinal magnetization increase along the Z axes to reach the M0 
value, the resultant magnetization in the XY plane decrease to zero. T2 relaxation is 
caused by transient magnetic fields at any frequency. It is determined by the 
combination of two contributions: molecular interactions and magnetic field 
disomogenity. T2 keeps getting shorter as molecular reorientation rates slow down. 
€ 
Mxy = M0e− t /T 2
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Figure 5.10 (A) Relaxation T1 comparison between residues of free HscB (blue) and HscB:IscS 
mixture (1:0.6) (red) at 298 K. 
 
Figure 5.10 (B) Relaxation T1 comparison. Difference between T1 values for the expected complex 
HscB:IscS and for the free protein HscB at 298 K. 
 
The estimated T1 resulted to be 1385±81 ms for the HscB:IscS mixture and 
1356±342 ms for free 15N-HscB. This would not support an overall change of the 
average value. However, when I calculated the difference between the T1 values for 
the expected complex and for the free protein, I could observe that for a relevant 
number of residues in a specific region of the protein (C-teminus), the T1 value 
variation overseeded the average of the differences (249 ms) plus one standard 
deviation (figure 5.10 (B)). This suggests that the protein is locally affected by the 
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The change in relaxation time, together with the crosslinking assay, confirmed that 
HscB could bind the desulfurase IscS.  
 
5.3 HscB binds IscS with micromolar affinity 
To complete the characterization of the interaction between IscS and HscB, this was 
quantified by determining the affinity constant of binding (KD). Several techniques 
allow the determination of the binding constant by measuring a biophysical property 
of the system. Among those I attempted was the most common, Isothermal Titration 
Calorimetry, which measures the heat exchanged, and Microscale thermophoresis 
which measures changes in the mobility of molecules in microscopic temperature 
gradients.  
 
5.3.1 Isothermal Titration Calorimetry 
When binding occurs, heat is either absorbed or released. This is measured by a 
sensitive calorimeter during gradual titration of the ligand into the sample cell 
containing the protein. The quantity of the heat measured is in direct proportion with 
the amount of the binding and provides the binding constants (KD), the reaction 




BOX 7 Principle of Isothermal Titration Calorimetry 
Isothermal Titration Calorimetry (ITC) measures heat evolved or absorbed in 
solutions as a result of mixing precise amounts of reactants. A pair of identical cells 
is enclosed within two shields; the inner shield is referred to the jacket. Both cells 
are completely filled with liquid during operation to avoid differences in volume. 
Temperature differences between the reference cell and the sample cell are 
measured. The output signal is the differential power (DP) between the reference  
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Titrating a solution of 40 µM IscS with a series of small aliquots of 320 µM HscB, I 
obtained a noisy curve perfectly superimposable with the curve of dilution of HscB in 
the buffer (20 mM Tris-HCl pH 8, 150 mM NaCl, 2 mM DTT) (figure 5.11). 
Furthermore a precipitate appeared in the cell suggesting that IscS is not stable in 
these conditions. 
 
cell and the sample cell. It represents the power used to maintain temperature 
equilibrium. 
In a typical experiment, a syringe containing a ligand is used to inject into the cell 
containing the protein to be titrated. If the reaction is exothermic, the injection 
results in the evolution of heat within the sample cell and causes a negative change 
in the DP. The opposite is true for endothermic reactions. 
The time integral of the peak yields a measurement of the thermal energy. This heat 
is released or absorbed in direct proportion to the amount of binding that occurs. 
When the protein in the cell becomes saturated with added ligand, the heat signal 
diminishes until only background heat of dilution is observed. A fitting model can be  
used to analyze ITC data and calculate reaction stoichiometry (n), binding constant  
(KD), enthalpy (∆H) and entropy (ΔS) using the equations of thermodynamic. 
€ 
ΔG = ΔH −TΔS = RT lnKD  
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Figure 5.11 (A) ITC measurements. Peaks indicate the heat released after each addition of binding 
protein HscB 320 µM into the cell containing IscS 40 µM in 20 mM Tris-HCl pH 8, 150mM NaCl, 2 mM 
DTT. In the lower panel data were converted in heat released per mole of HscB added. 
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Figure 5.11 (B) ITC asurements. Buffer (20 mM Tris-HCl pH 8, 150mM NaCl, 2 mM DTT) was titrated 
with 320 µM HscB to obtain a reference curve. 
 
ITC assays proved inconclusive to obtain a binding constant, as it can be expected 
for weak complexes. The quantitative determination of the binding between IscS 
and HscB needed an approach where a sensitive technique was used, able to 
reveal also weak interaction, and without particular conditions of temperature or pH 
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5.3.2 Microscale Thermophoresis 
Changes in the hydration shell, charge or size, of molecules cause changes of the 
mobility of molecules in a temperature gradient. This phenomenon is called 
thermophoresis. As the interaction of a molecule with another changes at least one 
of these properties, Microscale Thermophoresis (MST) turns out to be a sensitive 
means to measure also weak interactions (Jerabek-Willemsen, Andre et al. 2014) 
with a KD in the range of 1 nM - 500 mM. In MST molecular movements inside a 




BOX 8 Principle of MicroScale Thermophoresis 
MicroScale Thermophoresis (MST) can quatify a binding of two molecules by 
measuring the change in their mobility in a microscopic temperature gradient 
(thermophoresis). The target protein is labelled with a fluorescent dye and the 
movement is measured by monitoring the fluorescence distribution inside a 
capillary. The microscopic temperature gradient is generated by an IR-Laser, which 
is focused into the capillary and is strongly absorbed by water.  
Before heating, the initial constant value of fluorescence is recorded. When the IR-
Laser is switched on, an abrupt change in its intensity is observed. Fluorescence of 
the dye changes because of its intrinsic temperature dependence and also because 
molecules move from the locally heated region to the outer cold region. It reaches a 
plateau representing the steady state in which thermodiffusion is counterbalanced 
by mass diffusion. Immediately after the heating laser is turned off, fluorescence 
recovers and finally reaches a constant value (Seidel, Dijkman et al. 2013). Relative 






Where Finitial is the fluorescence measured before and Fhot after a defined time of IR- 
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NHS-ester is a suitable dye because it reacts efficiently with primary amines of 
proteins. Primary amine groups are found in lysine residues which are usually 
laser heating (Jerabek-Willemsen, Wienken et al. 2011). 
A typical MST experiment for quantification of an interaction is set up as a titration 
experiment. The concentration of a fluorescently labelled molecule is kept constant, 
whereas the concentration of an unlabeled binding partner is varied starting with a  
value at least 10 times above the expected dissociation constant down to sub-
stoichiometric concentration. Within the titration experiment Fnorm changes as 
 
Where Fnorm(A) is the contibution of the unbound fluorescent molecule A and 
Fnorm(AT) the contribution of the complex of the fluorescent molecule A with the 
interacting titrant T, x the fraction of the fluorescent molecules that formed the 
complex. 
By increasing the concentration of the non-labeled titrant, the fraction of complex 




The fraction of bound molecules x can be derived from the measured change in 
fluorescence. Considering that the concentration of free fluorescent molecule is 
€ 
A[ ] = A[ ]0 − AT[ ] , where [A]0 is kept constant during the experiments, and that for 
the free tritant it is 
€ 
T[ ] = T[ ]0 − AT[ ] , where [T]0 is the known concentration of added 





In the results the relative fluorescence Fnorm is plotted in %0 (Jerabek-Willemsen, 
Wienken et al. 2011). 
€ 
Fnorm = (1− x)Fnorm (A) + xFnorm (AT)
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solvent accessible and therefore convenient for labelling reactions. NT-647-NHS 
labelled proteins show fluorescence excitation and emission maxima of 
approximately 650 and 670 nm respectively.  
NHS was used to form highly stable dye-IscS conjugates as desulfurase IscS 
contains 15 lysines per monomer (30 per dimer) solvent exposed and suitable for 
the labelling.  
Obviously, the purified protein should be in a buffer that does not contain primary 
amines (e.g. Tris-HCl, glycine, glutathione) or imidazole and reducing agent, as DTT 
or β-mercaptoethanol, should also be avoided. I thus previoulsly exchanged the 
buffer from 20 mM Tris-HCl pH 8, 150 mM NaCl, 2 mM DTT to 100 mM 
carbonate/bicarbonate at pH 8.3 - 8.5 buffer with a PD-10 column.  
The reactive mixture containing IscS 20 µM and dye 60 µM was incubated overnight 
at 4 °C. Other conditions were avoided because IscS is not stable for long time at 
room temperature and it tends to aggregate. A clean-up step eliminated the 
unreacted free dye and exchanged again the buffer to 20 mM Tris-HCl pH 8, 150 
mM NaCl, 2 mM DTT passing the mixture through a NAP-5 column. The yield of the 
reaction was assessed spectroscopically by measuring the ratio of dye 
concentration with respect to total protein concentration.  
€ 
%[NHS − IscS] = [NHS][IscS] ⋅ 100 
Measuring the absorption at 280 nm for IscS and at 650 nm for the dye I determined 
that 1.3 µM of IscS contained NHS up to 4 µM of total protein. It means that only a 
third (32.5%) of molecules of IscS contained the dye. The detergent Tween-20 was 
added to the sample to avoid the presence of potential aggregates that influence the 
fluorescence signal. 
To avoid experimental artifacts, which can be caused by protein adsorbance to the 
glass capillary or by protein aggregations, different capillary types were tested. The 
fluorescence of three capillaries for each available type (standard, hydrophobic and 
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hydrophilic) was measured. With standard and hydrophobic capillaries I observed 
shoulders in the fluorescence peaks. On the contrary non-sticking behaviour with 
symmetric shape was showed with hydrophilic capillaries (figure 5.12). 
 
 
Figure 5.12 Test of MST standard (left), hydrophobic (center) and hydrophilic (right) capillaries 
containing IscS 50nM. 
 
HscB was dissolved to a final concentration of 473 µM in a buffer containing 20 mM 
Tris-HCl pH 8, 150 mM NaCl, 0.5 mM TCEP, 0.05% Tween-20 and with labelled 
IscS at a concentration of 50 nM. This stock solution was then serially diluted 1:1 
using the same buffer to give 12 working solutions with different HscB concentration 
but the same fluorophore concentration (from 473 µM to 115 nM). The 
thermophoretic movements of labelled IscS in the sample solutions were assessed 
by measuring fluorescence distribution inside the capillary. Measurements were 
performed using different light-emitting diode power and 17% of infrared-laser 
power. 
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Figure 5.13 MST Data for the IscS and HscB interaction. HscB was dissolved to a final concentration 
of 473 µM in a buffer containing 20 mM Tris-HCl pH 8, 150 mM NaCl, 0.5 mM TCEP, 0.05% Tween-20 
and labelled IscS at a concentration of 50 nM was added. This stock solution was serially diluted 1:1 to 
give 12 working loaded into hydrophilic capillaries and MST measurement were made at 25 °C using 
50% light-emitting diode power and 17% of infrared-laser power. Data are plotted as normalized signal 
changes as a function of th HscB consentration. The average of three experiments is reported.  
 
The binding curve was obtained by plotting the fluorescence versus the logarithm of 
the progressively diluted concentrations of HscB (figure 5.13). The data obtained 
with different values of light emitting diode (LED) were directly analysed with the 
software of the instrument and resulted in a dissociation constant (KD) of 10 - 30 µM 
assuming a 1:1 stoichiometry. These affinities are low but comparable to those 
observed for other components of the Isc machine (Prischi, Konarev et al. 2010) 




In the first part of my PhD I proved that chaperones, and in particular the co-
chaperone HscB, slow down the rate of the overall Fe-S cluster biosynthesis, 
without differentiating on which level they act. However, several studies have been 
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the specific steps of the Fe-S cluster biosynthesis leading to controversial results. 
Chandramouli and Johnson first studied the second step of the machinery. They 
showed that chaperones stimulate Fe-S cluster transfer from IscU to apo-Fdx 
(Chandramouli and Johnson 2006). A few years ago, a study by Bonomi and 
coworkers investigated the formation of the Fe-S cluster on IscU. They showed that, 
independently from the initial source of sulfur (chemical or enzymatic), the presence 
of HscA, HscB and ATP causes as an inhibitory effect (Iametti, Barbiroli et al. 2015).  
I decided to probe the inhibitory influence of HscB on the first step of the Fe-S 
cluster biosynthesis in which the cysteine is converted into alanine by desulfurase 
IscS. Monitoring by mass spectrometry the amount of these amino acids during the 
reaction, I demonstrated that HscB slows down also cysteine desulfuration.  
Although the inhibitory effect was previously interpretated as to be related to the 
interaction between HscB and IscU (Iametti, Barbiroli et al. 2015), in my assay IscU 
was absent. I thus explored the possibility of a previously unidentified direct binding 
between the co-chaperone and the desulfurase. I tested the binding with several 
assays (pull-down, size exclusion chromatography). However, only using 
crosslinking and NMR techniques, which can detect also weak interactions thanks to 
their high sensitivity, I could prove that HscB and IscS interact.  
The biological relevance of the interaction cannot easily be doubted since the affinity 
KD is around 10 µM and thus consistent with the KD values established for other Isc 
interactions (∼20 µM for IscS-CyaY (Prischi, Konarev et al. 2010); ∼13 µM for HscB-
IscU (Hoff, Silberg et al. 2000)). However, taking in accont of the different conditions 
and methods of measurement, it is difficult to establish if the quantitative 
comparison of the KDs reflects the extent of competition of two different proteins for 
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5.5 Methods 
Mass Spectrometry 
Cysteine consumption and alanine formation were obtained with 1 µM IscS, 3 mM 
DTT and 250 µM cysteine in 20 mM Tris-HCl at pH 8 and 150 mM NaCl. When 
necessary, 3 µM HscB was added. The reaction was stopped with a mixture of 
acetic acid (0.1%)/acetonitrile (100%) after 0, 10, 20, 40 and 60 min. Determination 
of alanine and cysteine was performed by mass spectrometry facility at King’s 
College London with HR-LCMS using a Thermo Accela Pump and Pal Autosampler 
coupled to a Thermo EXactive. Chromatographic separation was performed on a 
ODS Hypersil 150x2.1 mm 3u column maintained at room temperature. A 10 min 
gradient was employed using a mobile phase A with 0.1% formic acid in water and a 
mobile phase B in 0.1% formic acid in acetonitrile: the composition was maintained 
at 95% A for the first 5min. A 100% composition of A was held for 0.7 min and then 
decreased to 95% A over the next 4.3 and held until 10 min. Electrospray (ESI) 
mass spectrometry measurements were performed operating with a capillary 
voltage of 4.0 kV in positive ion mode, auxiliary gas flow of 10 Arb., sheat gas flow 
of 60 Arb., capillary temperature of 320 °C. The instrument was set to acquire over 
the mass range m/z 80 - 130 with an acquisition time of 10 min. The mass 
spectrometer was calibrated with solutions of alanine and cysteine in the 
concentration range of 0 - 500 ng/ml.  
 
Pull-down assays 
Glutathione-Sepharose and Ni-NTA resins were equilibrated in a buffer containing 
20 mM Tris-HCl pH 8, 150 mM NaCl, 2 mM DTT. Mixtures of the His, GST-tagged 
HscB and IscS or His-IscS and HscB in the ratio 1:10 (tagged:untagged protein) 
were prepared, loaded on a Ni-NTA or on a glutathione sepharose resin and 
incubated for 30 minutes. After extensive washing with the same buffer and 
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centrifugation, supernatant and resins were separated and loaded on a SDS PAGE 
gel. 
 
Size Exclusion Chromatography 
Analytical SEC experiments were performed on a Superdex200 Increase 10/300 GL 
column equilibrated in 20 mM Tris-HCl pH 8, 150 mM NaCl, 2 mM DTT. The eluant 
was monitored at 280, 250 and 392 nm. Fractions were collected and proteins 
analysed by SDS PAGE gel.  
 
Crosslinking 
A mixture of IscS 5 µM and HscB 30 µM was prepared in PBS buffer. Dimethyl 
adipimidate or Bis[sulfosuccinimidyl]suberate were added to the protein sample to a 
final concentration of 1.3 mM. The reaction mixture was incubated at room 
temperature for 30 minutes and quenched by adding Tris-HCl at pH 8 to a final 
concentration of 20 mM. The quenching reaction was incubated at room 
temperature for 15 minutes. SDS PAGE was run to determine crosslinked species. 
 
15N-labelled protein expression 
15N-labelled proteins were prepared for T1 relaxation NMR measurements. 
Plasmids were incorporated by BL21(DE3) E. coli cells and these were grown in 
minimal medium composed by M9 salts with 3 g/L of D-glucose and using 1 g/L of 
(15NH4)2SO4 as the sole source of nitrogen. Proteins were then expressed and 
purified as previously described. 
 
T1 relaxation NMR measurement  
15N T1 values were measured at 298 K, with  a Bruker AVANCE III spectrometer at 
700 MHz proton frequency, using  uniformly 15N-enriched HscB (0.160 mM), alone 
and in the presence of 0.093 mM IscS. The relaxation series was recorded as a 
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pseudo 3D experiment with scan-wise interleaving, with parametric T1 relaxation 
delays of 10, 100, 200, 400, 700, 1000, 1500, 2000 and 2500 ms. An overall T1 
relaxation time estimate was obtained by averaging the T1 values after excluding 
residues with a weighted root mean square (wrms) of fitting lower than 0.75 or 
higher than 1.25.  
 
Isothermal Titration Calorimetry 
ITC experiments were performed on an ITC200 microcalorimeter interfaced with a 
computer for data acquisition and analysis by Origin 7 software. Before the 
measurements, proteins were dialysed against 20 mM Tris-HCl pH 8, 150mM NaCl, 
2 mM DTT. IscS 40 µM was titrated in the calorimetric cell thermostated at 18 °C 
with successive injections of a 320 µM stock solution of HscB spaced at 120 s 
intervals. The titration syringe was continuously stirred at 1000 rpm. For the first 
injection, only 0.2 µL of HscB were added and the corresponding data point was 
excluded from analysis. Injections were started after baseline stability had been 
achieved. A reference titration of dilution was carried out by injecting HscB into the 
calorimetric cell containing only the buffer. Data obtained were fit using a single-site 
sequential binding model. 
 
Microscale Thermophoresis 
MST measurements were performed using a NanoTemper Monolith NT.115 
instrument. IscS samples were labelled with the amine-reactive dye NT-647 using 
the Monolith NT.115 Protein Labelling Kit RED-NHS. The reactive mixture was 
incubated overnight at 4 °C. Labelling levels were determined using ε280 (IscS)= 
41370 M-1cm-1 and ε650 (dye)= 250000 M-1cm-1. HscB was dissolved to a final 
concentration of 473 µM in a buffer containing 20 mM Tris-HCl pH 8, 150 mM NaCl, 
0.5 mM TCEP, 0.05% Tween-20 and labelled IscS at a concentration of 50 nM was 
added. This stock solution was serially diluted 1:1 to give 12 working solutions with 
different HscB concentration and mantaining the fluorophore concentration constant. 
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Solutions were loaded into hydrophilic capillaries and MST measurement were 
made at 25 °C using 40 - 60% light-emitting diode power and 17% of infrared-laser 
power. 
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6. STRUCTURAL APPROACH  
A further step in the characterisation of the binding between two proteins is the 
individuation of their surface of interaction. Since structure is strongly connected 
with function, it is important to identify which residues are involved. Depending on 
the site of binding, the activity of a protein could be affected. For this reason, 
structural studies often lead to relevant conclusion on the biological importance of 
proteins interactions. 
 
6.1 HscB surface of interaction 
NMR is usually used because this is a powerful technique able to detect binding 
between proteins also if they interact with low affinity (in the uM-mM range). The 
only limit is the inability of detecting directly proteins above ca. 30 kDa, such as is 
IscS that has a molecular weight of 90 kDa. When the molecular size increases the 
tumbling rate of the molecule slows and the slow tumbling will cause the 
magnetisation to dephase rapidly causing the NMR signal to broaden and decay 
quickly. For this reason, I first started with the investigation of the binding surface on 
the HscB site. 
 
6.1.1 NMR-HSQC Spectra 
The Heteronuclear Single Quantum Correlation (HSQC) is an example of 2-
Dimensional NMR experiment. HSQC-NMR spectra appear as an ensamble of 
spots corresponding to resonances. They provide a fingerprint of proteins because 
each resonance corresponds to a N-H group and its position, chemical shift, in the 
spectrum depends on the chemical environment of the amino acid in the protein. If 
the assignement is known, it will be possible to correlate each resonance with its 
residue.  
NMR thus allows direct identification of the amino acids involved in the surface of 
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interaction thanks to the possibility of identifying changes of their chemical 
environment upon the binding. When two molecules interact, what is expected is a 
shift of the peaks for which the environment has changed because of an 
involvement of the corresponding amino acids or a conformational change in the 
chain. However, since the formation of a complex slows down the tumbling of the 
two single molecules, it could happen that some resonances disappear because of 
broadening of the signal due to faster relaxation and longer correlation times. 
 
 
BOX 9 Principle of the NMR-HSQC experiment  
NMR spectroscopy is based on the excitation of a sample upon introduction of it into 
a magnetic field and irradiation by a radio frequency. The irradiation excites the 
nuclear spins from the ground to an excited state. The signal obtained can be 
recorded as a plot of the energy emitted as a function of time. This signal, which 
contains all the information needed, can successively be Fourier transformed to a 
plot which reports the energy emitted as a function of frequency, which corresponds 
to the traditional NMR spectrum. A direct extension of this mono-dimensional 
spectrum is the two-dimensional NMR spectroscopy, in which the signal is recorded 
as a function of two time variables, t1 and t2, and the resulting data Fourier are 
transformed twice to yield a spectrum which is a function of two frequency variables. 
  
 
Figure 6.1 General scheme for 2D-NMR  pulse sequence. 
 
In the first period, called preparation time, the sample is excited by one or more 
pulses. The resulting magnetization is allowed to evolve for the first time period, t1. 
During the mixing period, coherence is transferred from one spin to another. Mixing 
sequences use two mechanisms for magnetization transfer: scalar coupling or  
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In order to obtain HscB selectively enriched in 15N, I expressed it in E. coli and I 
grew cells in minimal medium containing 15N-ammonium. The HSQC Spectrum of 
free HscB 100 µM in 20 mM Tris-HCl pH8, 150 mM NaCl and 2 mM DTT was 
recorded at 298 K. 
The structure of the co-chaperone HscB has been already studied in literature and 
depositated in the Protein Data Bank (PDB code: 1FPO). The chemical shifts of its 
HSQC spectrum are already available in the Biological Magnetic Resonance 
Database (BMRD) (entry ID 15541). Spectra have been recorded by Fuzery in 
conditions not completely comparable to mine (Fuzery, Tonelli et al. 2008): buffer 
contained around 20 mM Tris-HCl, 10 mM DTT and temperature was set at 313 K. 
Since the major difference can be attributed to the temperature (298 K in my 
experiments), to use this entry as base for the assignment, I recorded HSQC-NMR 
dipolar interaction. At the end of the experiment, the signal is recorded as a function 
of the second time variable t2. 
Apart from protons, proteins contain other magnetically active nuclei, such as 15N  
and 13C. One particular useful experiment is to record a 2D spectrum in which 
protons are correlated to the heteroatom to which they are scalarly coupled so that 
the coordinate of a peak in one dimension is the 1H chemical shift and the 
coordinate in the other dimension is the chemical shift of the nucleus to which it is 
coupled. 15N-Heteronuclear Single Quantum Correlation (HSQC) experiments 
correlate the nitrogen atom of amines with the directly attached proton, so each 
signal in a HSQC spectrum represents a proton that is bound to a nitrogen atom. 
Since there is only one H-N per amino acid, each HSQC signal represents one 
single amino acid. The HSQC also contains signals from the NH2 groups of the side 
chains of Asparagine and Glutamine and of the aromatic H-N of Tryptophan and 
Histidine. Analogous experiment can be performed for 13C and 1H. 
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spectra of HscB at different temperature (313, 308, 303 and 298 K) (figure 6.2). For 




Figure 6.2 15N HSQC spectra of HscB at different temperatures, recorded at 313 (maroon), 308 
(red), 303 (cyan) and 298 K (green) with a protein concentration of 100 µM in 20 mM Tris-HCl pH 8, 
150 mM NaCl and 2 mM DTT. 
 
I recorded the 15N HSQC NMR experiments of free HscB (100 µM) and identified all 
the residues according to the BMR database entry. A 15N labelled HscB sample was 
then titrated with unlabelled IscS in the 1:1 and 1:2 HscB:IscS molar ratio and 15N 
HSQC NMR experiments recorded (figure 6.3). 
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Figure 6.3 HSQC-NMR spectra of 15N-labelled HscB 100 µM (black) and 15N-labelled HscB 100 µM 
in the presence of IscS 1:1 (red) at 298 K in 20 mM Tris-HCl pH 8, 150 mM NaCl and 2 mM DTT. 
Bottom: Zoom of a relevant region of the spectrum for the identification of the binding. 	  
The residues of HscB involved in the interaction were mapped. At a 1:1 IscS/HscB 
molar ratio, many peaks, amongst which those from the J-domain, did not shift. This 
suggested that IscS has a minimal effect on these regions of HscB. Other 
resonances (L22, H63, Q95, R99, E104, E106, E111, I118, K119, M124, L157, 
A161 and D170) had small but detectable chemical shift changes indicative of 
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environmental changes in the presence of IscS. A third set of residues (I105, I118, 
F125, H129, L131, L136, E139, L151, D155, R158, E162 and K167) broadened 
significantly (see appendix I.I for data analysis). At the end of the titration, the HscB 
spectrum disappeared almost completely as expected for the formation of a 
complex with molecular weight of 130 kDa (assuming a 1:1 stoichiometry). 
 
 
Table 6.1 HscB residues affected in the HSQC spectrum after the addition of IscS. 
 
As we can see in figure 6.4, HscB presents a shape similar to a swiss knife made by 
two domains. Residues affected are mainly located on the C-terminus and map on 
the internal surface facing the J-domain.  
 
Figure 6.4 Mapping the interaction surface on HscB (PDB code: 1FPO). Residues showing 
chemical shift perturbation at a 1:1 molar ratio are shown in yellow, those which broaden or disappear 
in magenta.  
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6.1.2 NMR-Cross saturation experiments 
When two or more molecules interact, part of a chain can rearrange changing its 
tridimensional position. Thus some amino acids can be affected by a different 
chemical environment without mapping in the surface of binding and they can 
present resonance at a different chemical shift comparing with the spectrum of the 
free protein. Cross saturation is a NMR technique more powerful than the simple 
chemical shift/disappearance in the HSQC spectra because it is able to distinguish 
residues that directly interact from those which undergo conformational 
rearrangements (Takahashi, Nakanishi et al. 2000).  
 
 
BOX 10 Principle of NMR-Cross saturation experiment 
Cross saturation is an NMR measurement technique which can identify the direct 
interface between molecular complexes. This technique is particularly helpful for weak 
high molecular complexes in which one component is easily within the smaller NMR 
size range and the other too large to allow easy detection.  
In these experiments, if the two molecules are both proteins, one of the two interacting 
components (protein I) is uniformly labelled with 2H and 15N and complexed with a non-
labelled protein (protein II). The complex is thus composed of molecules with lower 
(protein I) and higher (protein II) proton densities. In the case of the protein with higher 
proton density, if the aliphatic proton resonances are irradiated non-selectively using a 
radio frequency field, not only its aliphatic resonances but also its aromatic and amide 
protons are instantaneously saturated. This phenomenon is well known as spin 
diffusion effect. Although the protein uniformly labelled with 2H and 15N is not directly 
affected by the radio frequency field, it is expected that saturation can be transferred 
from the target molecule (protein II) to the doubly labelled molecule (protein I) by cross  
relaxation through the interface of the complex. If the proton density of the doubly 
labelled molecule is sufficiently low, the saturation transferred is limited to the interface  
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Cross saturation experiments were recorded to discriminate between residues of 
HscB that are effectively involved in the surface of interaction with IscS and residues 
which are only affected by a change in conformation. In this experiment HscB was 
uniformly labelled with 2H and 15N with level of deuteration of around 90%. HscB 
free (100 µM) was not completely unaffected by cross saturation sequence because 
some protons were still present in the protein side chains. After the addition of IscS 
(1:1) the saturation was transferred from IscS to HscB through the interface of the 
complex by cross relaxation. However, it was transferred only to the directly 
exposed surface of HscB. I plotted the difference between the TROSY spectrum 
recorded in the experiment with the aliphatic hydrogen saturated and the spectrum 
in which the aliphatic radio frequence was off and I compared the experiment 
performed on HscB in the presence of IscS (1:1) with that on HscB free (figure 6.6). 
 
of interaction. Therefore residues at the interface of protein I can be identified by 
observing the reductions of the peak intensities in the 1H-15N HSQC spectrum 
measured by TROSY coherence transfer (Takahashi, Nakanishi et al. 2000). 
 
 
Figure 6.5 Representation of the principles of cross saturation method. 
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Figure 6.6 Cross saturation experiment on 2H,15N-labelled HscB 100 µM (black) and in the presence 
of IscS 1:1 (blue) at 298 K in 20 mM Tris-HCl pH 8, 150 mM NaCl and 2 mM DTT. Saturation of 
aliphatic resonances was achieved with a pulses centered at 0.5 ppm. The intensity of the amide 
peaks in the experiment in which the aliphatic hydrogen were saturated was compared with the 
intensity of the amide peaks in the control off-resonance experiment. 
 
The following residues were observed to be affected: L22, Q49, Q56, 
A80, Q95, D110, E111, K119, S160, Q163, E166, D170, and F171 (see appendix I.I 
for data analysis). 
 
 
Table 6.2 HscB residues affected by cross saturation after the addition of IscS. 
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Most of these are close in space and located in the C-terminus of the approximately 
L-shaped HscB structure and form an exposed patch (figure 6.7). 
 
 
Figure 6.7 Mapping the HscB surface of interaction (PDB code: 1FPO). Cross saturation revealed 
residues of HscB involved on the surface of interaction with desulfurase IscS at molar ratio 1:1 
(evidenced in blue). 
 
6.2 IscS surface of interaction 
It is well known in literature that desulfurase IscS is able to bind several proteins 
(Shi, Proteau et al. 2010). Since it is involved in different pathways (such as tRNA 
modification and molybdenum cofactor and Fe-S cluster biosynthesis), its possible 
partners are encoded by different operons. Among the proteins involved in the Fe-S 
cluster biosynthesis, IscU, ferredoxin, CyaY and YfhJ interact with IscS and these 
interactions are correlated with a specific role in the machinery. While IscU interacts 
with only one subunit of the IscS dimer (so two molecules are bound for a dimer) 
(Urbina, Silberg et al. 2001), CyaY frataxin binds IscS in a pocket between the 
active site and the IscS dimer interface and touches both the IscS units (Prischi, 
Konarev et al. 2010). Fdx competes for the same binding site (Yan, Konarev et al. 
2013), whereas leaving the interaction with IscU unchanged. In addition, the Fdx 
binding site overlaps also with the other less known protein YfhJ (Pastore, Adinolfi 
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et al. 2006). Looking at this information, I was interested in the IscS surface of 
binding: does the HscB binding site overlap with other proteins?  
IscS spontaneously forms a dimer of 90 kDa. Unfortunately, proteins and systems of 
this dimension are too large to be detectable with standard NMR experiments: 
peaks broaden to the point that the spectrum completely disappears. To identify the 
surface of IscS interacting with HscB, I tested the ability of IscS mutants designed 
ad hoc to affect the HscB spectrum: if the mutant is still able to bind, the resulting 
spectrum is expected to correspond to that obtained in the presence of IscS wild 
type. On the contrary, if mutations impact residues participating on the binding, the 
interaction will be at least partially repressed and the spectrum appears as for HscB 
free. Plasmids expressing variants of IscS which affect different regions of the 
protein were already available in our laboratory because they had been used in the 
study of the complex made by IscS and bacterial frataxin, CyaY, (Prischi, Konarev 
et al. 2010) or ferredoxin, FdX (Yan, Konarev et al. 2013): IscS_R39E/W45E, 
IscS_K101E/K105E, IscS_R220E/R223E/R225E, IscS_I314E/M315E and 
IscS_E334S/R340S (figure 6.8). Circular dichroism had been measured in the past 
and supported that the mutants are all correctly folded as expected from their 
location in exposed regions of the enzyme.  
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Figure 6.8 Position of the mutations on the structure of IscS (PDB code: 3LVL). 
 
As with the wild type, I recorded the HSQC spectrum of 15N-labelled HscB in the 
presence of each IscS mutant at molar ratio 1:1. Among them, IscS_R39E/W45E, 
IscS_R220E/R223E/R225E and IscS_K101E/K105E leave mostly unaffected the 
spectrum of HscB (figure 6.9 (A, B, C)). This means that mutations of these residues 
result in complete or partial abolishment of the binding. Conversely, the spectra with 
IscS_E334S/R340S and IscS_I314E/M315E are affected by IscS addition 
comparably to wild-type, indicating that these residues are not involved in the 
interaction (figure 6.9 (D,E)).  
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Figure 6.9 (A) Identification of the surface of interaction on IscS by mutagenesis. HSQC-NMR 
spectra of 15N-labelled HscB 100 µM (black) and in the presence of the IscS_R39E/W45E (1:1) (red) at 
298 K in 20 mM Tris-HCl pH 8, 150 mM NaCl and 2 mM DTT. 
 
Figure 6.9 (B) Identifiction of the surface of interaction on IscS by mutagenesis. HSQC-NMR 
spectra of 15N-labelled HscB 100 µM (black) and in the presence of the IscS_R220E/R223E/R225E 
(1:1) (red) at 298 K in 20 mM Tris-HCl pH 8, 150 mM NaCl and 2 mM DTT. 
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Figure 6.9 (C)Identifiction of the surface of interaction on IscS by mutagenesis. HSQC-NMR 
spectra of 15N-labelled HscB 100 µM (black) and in the presence of the IscS_K101E/K105E (1:1) (red) 
at 298 K in 20 mM Tris-HCl pH 8, 150 mM NaCl and 2 mM DTT.  
 
 
Figure 6.9 (D) Identifiction of the surface of interaction on IscS by mutagenesis. HSQC-NMR 
spectra of 15N-labelled HscB 100 µM (black) and in the presence of the IscS_E334S/R340S (1:1) 
(orange) at 298 K in 20 mM Tris-HCl pH 8, 150 mM NaCl and 2 mM DTT.  
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Figure 6.9 (E) Identifiction of the surface of interaction on IscS by mutagenesis. HSQC-NMR 
spectra of 15N-labelled HscB 100 µM (black) and in the presence of the IscS_I314E/M315E (1:1) 
(orange) at 298 K in 20 mM Tris-HCl pH 8, 150 mM NaCl and 2 mM DTT.  
 
A similar behaviour was reported with the bacterial frataxin CyaY and for Fdx which 
also form complexes with IscS. 
 
6.3 Compatibility of HscB binding with other proteins 
Both HscB and IscS are involved in binding with several other proteins of the Isc 
machinery and of other systems. It was thus interesting to investigate if some of 
these proteins affect the HscB/IscS interaction. 
 
6.3.1 HscB, CyaY and FdX compete for the same site on IscS 
The results obtained suggested that HscB binds IscS in a site overlapping with that 
observed for frataxin, CyaY, (Prischi, Konarev et al. 2010) and ferredoxin, FdX (Yan, 
Konarev et al. 2013). To validate the hypothesis, I titrated a sample containing the 
HscB/IscS complex with CyaY (up to a 1:1:3 molar ratio) or Fdx (up to a ratio 1:1:3).  




Figure 6.10 (A) Competition experiments of HscB with CyaY and FdX. Superposition of the HSQC 
spectra of 100 µM free 15N-labelled HscB (black) and in the complex with unlabelled IscS 1:1 (blue) at 
298 K in 20 mM Tris-HCl pH 8, 150 mM NaCl and 2 mM DTT. The experiment is summarized 
schematically below. 
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Figure 6.10 (B) Competition experiments of HscB with CyaY and FdX. HSQC spectra of 100 µM 
15N-labelled HscB (black) and in complex with IscS with the addition of CyaY (1:1:1) (magenta) at 298 
K in 20 mM Tris-HCl pH 8, 150 mM NaCl and 2 mM DTT. The experiment is summarized schematically 
below. 
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Figure 6.10 (C) Competition experiments of HscB with CyaY and FdX. HSQC spectra of 100 µM 
15N-labelled HscB (black) and in the presence of IscS and apo-Fdx (1:1:3) (green) at 298 K in 20 mM 
Tris-HCl pH 8, 150 mM NaCl and 2 mM DTT. The experiment is summarized schematically below. 
 
I observed that introduction of CyaY causes the progressive reappearance of the 
spectrum of HscB, consistent with its almost complete displacement from IscS at 
1:1:1 (figure 6.10 (B)). Titration of the HscB/IscS complex with Fdx also regenerates 
the spectrum of HscB but, at a higher molar ratio: at a 1:1:3 ratio of IscS/HscB/Fdx, 
the spectrum of HscB is only partially restored (figure 6.10 (C)). This confirmed that 
the interaction between IscS and HscB involves the same site that hosts CyaY and 
Fdx. The site involves a cleft formed between the two protomers of the IscS dimer 
and contains PLP and the catalytic centre (Cupp-Vickery, Urbina et al. 2003). 
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6.3.2 IscU does not compete with IscS/HscB binding 
It is well known that HscB is able to bind the scaffold protein IscU and that this 
interaction enhances the ATPase activity of HscA (Chandramouli and Johnson 
2006). Whereas the co-chaperone binds its partner HscA through R152, D155, 
K156, R158 and Q163, (Fuzery, Tonelli et al. 2008) the binding with IscU involves 
residues R87, L92, L96, R99, E100 and F153 (Fuzery, Tonelli et al. 2008, Kim, 
Fuzery et al. 2009, Fuzery, Oh et al. 2011). Both surfaces of interaction belong 
prevalently to the C-terminus domain (figure 6.11). On the contrary, the interaction 
with IscS was completely unkown before. NMR allowed the identification of the 




Figure 6.11 Mapping the HscB surface of interaction with HscA (green), IscS (blue) and IscU 
(red). 
 
Since the scaffold protein IscU is able to bind both the desulfurase IscS and HscB, I 
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Figure 6.12 (A) IscU does not compete with IscS binding. Comparison of the spectra of 15N-labelled 
IscU (top), the same but after addition of HscB 1:0.4 (middle) and after the further addition of IscS 
1:0.4:0.4 (bottom) at 298 K in 20 mM Tris-HCl pH 8, 150 mM NaCl and 2 mM DTT. 
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Figure 6.12 (B) IscU does not compete with IscS binding. Comparison of the spectra of 15N-labelled 
HscB (top), the same but after addition of IscU 1:1 (middle) and after the further addition of IscS 1:1:1 
(bottom) at 298 K in 20 mM Tris-HCl pH 8, 150 mM NaCl and 2 mM DTT. 
 
I recorded the HSQC spectrum of a sample of 15N labelled IscU where I added 
unlabelled HscB (1:0.4 IscU:HscB). I observed the typical chemical shifts expected 
for binding. I then added unlabelled IscS (1:0.4:0.4) and observed further 
disappearance of the spectrum (figure 6.12 (A)). Since also the complex composed 
by IscU and IscS is too big to be detectable with NMR, this result could simply mean 
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a displacement of HscB. Thus I also titrated labelled HscB with unlabelled IscU, to 
which I added unlabelled IscS (1:1:1). Also in this case the spectrum disappeared 
almost completely (figure 6.12 (B)). It can be noted that this result is not due to IscU 
displacement and HscB/IscS formation because in this last case the 15N-HscB 
spectrum would have disappeared only partially. 
These results conclusively indicate that the interaction between HscB and IscU is 
compatible with a furter binding with IscS.  
 
6.4 Further evidences about the HscB/IscS interaction 
All these studies provided significant information about the structure of HscB-IscS 
complex. I thus used the power of molecular docking to build models and add 
indications about the specific contacts between the two proteins. These new hints 
were then validated. 
 
6.4.1 Molecular docking of the HscB-IscS complex 
The software HADDOCK was used to draw and visualise the tridimensional low 
resolution structure of the HscB-IscS complex. It is a free platform available online 
which models structures of complexes starting from structures of single constituents, 




BOX 11 Principle of HADDOCK 
HADDOCK (High Ambiguity Driven biomolecular DOCKing) is a docking approach 
for the modelling of biomolecular complexes (e.g. protein-protein, protein-nucleic 
acids and protein-small molecule) (Dominguez, Boelens et al. 2003). This is driven 
by a wide variety of experimental and/or bioinformatics data (Melquiond 2010): 
usually interface regions are put as restrains of the docking. They could be identified  
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In the input file, HscB residues L22, Q49, Q56, A80, Q95, D110, E111, K119, S160, 
Q163, E166 and D170 were imposed as active Ambiguous Interaction Restrains 
(AIR) because detected by cross saturation experiments, while the IscS residues 
R220, R223, R225, R39, W45, K101 and K105 were chosen because they are 
involved in interaction as supported by the mutant studies. Residues directly 
adiacent to the surface were defined automatically by the program as Passive AIRs. 
HADDOCK returned 29 structures distributed in 5 clusters (table 6.3). 
by mutagenesis, H/D exchange and chemical modifications (e.g. by crosslinkers or 
oxidative agents) detected by mass spectrometry, nuclear magnetic resonance, 
chemical shift perturbations and cross saturation. When experimental data are 
unavailable or scarce, this information can be supplemented by bioinformatics 
predictions (de Vries 2008). These information sources typically only identify or 
predict interfacial regions and do not define the contacts across an interface. 
HADDOCK defines the interfacial regions as ambiguous interaction restraints (AIRs) 
and it forces the interfaces to come together without imposing a particular 
orientation.  
The docking protocol in HADDOCK consists of three successive steps: rigid-body 
energy minimization, semi-flexible refinement in torsion angle space and final 
refinement in explicit solvent refinement. HADDOCK can account for small 
conformational changes occurring upon binding. The selection of the final models is 
based on a weighted sum of electrostatics, desolvation and Van der Waals energy 
terms, along with the energetic contribution of the restraints used to drive the 
docking. 
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Table 6.3 Statistics for the HscB-IscS docking by HADDOCK. 
 
The clusters obtained mainly differed for the orientation of HscB that occupies the 
cavity centred on the IscS residues R220, R223 and R225 (figure 6.13). Each 
cluster is associated to a Z-score that indicates how many standard deviations far 
from the average the cluster is located in terms of score, the more negative being 
the better. Clusters 5 and 2 were the most energetically favourable with a Z-score of 
-1.3 and -0.6 respectively that is not significantly lower than the others. Even if 
cluster 5 produces a better statistic, cluster 2 clearly shows a structure where 
residues responsible for the binding are better orientated toward IscS. At the same 
time the binding surface area for IscU is positioned in an exposed area and thus 
available for a further binding. 
 
Figure 6.13 Structure of the most energetically favourable clusters (cluster 2 and 5) obtained with 
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starting structures. For IscS active ambiguous interaction restraints (AIRs) were defined as R220, 
R223, R225, R39, and W45, for the first protomer and K101 and K105 for the second promoter; for 
HscB, residues detected by cross saturation experimentsactive were defined as AIRs. Passive AIRs 
were defined automatically. 
 
Several polar contacts were identified in the predicted structures and it could be 




Table 6.4 Polar contacts between HscB and IscS in the formation of the complex as identified in 
HADDOCK clusters 5 and 2. 
 
Observing the HADDOCK models, it was evident that HscB approaches the 
desulfurase to its exposed positive patch through a negative surface (figure 6.14). 
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Figure 6.14 Electrostatic surfaces of HscB (left) and IscS (right). The two proteins interact through 
charged patches. 
 
6.4.2 HscB binds IscS through negatevely charged residues 
The surface of interaction on HscB was validated by designing acid-to-base 
mutations chosen among target residues that could potentially affect the interaction: 
E100, E111, E115, E165 and E166 from the C-terminal and E134, D137 from the 
region at the interface with the J-domain. I mutated acidic residues into lysines to 
invert the charge of the patch close to the surface involved. HscB_E100K, 
HscB_E111K/E115K, HscB_E134K/D137K and HscB_E165K/E166K mutants were 
designed to affect solvent exposed residues without altering the stability of the 
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Figure 6.15 Position of the mutations on the structure of HscB (PDB code: 1FPO) 
 
In order to introduce point mutations on HscB, the plasmid encoding for the wild-
type protein was amplified by polymerase chain reaction using oligonucleotide 







BOX 12 Principle of site-directed mutagenesis 
A polymerase Chain Reaction (PCR) is a rapid method for cloning genes and 
duplicate DNA sequence in large amount. The DNA polymerase used is a heat 
stabile enzyme that synthesises strands of DNA complementary to the DNA 
template, the sequence of interest to be amplified. Primers, short pieces of single-
stranded DNA, bind specifically to the complementary 3’ end of the target sequence 
and allow the polymerase to synthese new DNA in the presence of nucleotides.  
When a substitution mutation is desired, one of the primers must contain the desired 
mutation thus forming a mismatch with the template strand on the plasmid. The 
product of the PCR is a linearized plasmid containing the mutation at one end. 
Every PCR cycle consists in three steps: separation, annealing and synthesis. 
	   127	  
 
 
Separation of the two strands of the DNA double helix to create single strands 
occurs at very high temperature, 94 - 96 °C. The temperature is then lowered to 
allow primers to bind the DNA. Optimal binding temperatures can vary because 
different primers anneal at different temperatures, but they are usually around 60°C. 
Then the temperature is raised to 72 °C to allow the DNA polymerase enzyme to 
synthesis new strands of complementary DNA using free nucleotides in solution. 
The reaction may be cycled 20 - 40 times depending on the number of copies of 
DNA required, the purity and amount of the sample. The number of mutated DNA 
sequence increase exponentially every cycle. 
 
Figure 6.16 Overview of site-directed mutagenesis method. 
 
After amplification, the parental plasmid must be degradated using DpnI to prevent 
false positive that may occur due to the higher transformation efficiency with the 
template plasmid. When PCR reaction yields a highly contaminated product, it may 
be convenient to purify the DNA. A ligation step is used to recircularize the 
mutagenized plasmid. If 5’-phosphorylated primers are used, the ligation step can 
be performed directly after DpnI digestion. In contrast if unmodified oligonucleotides 
are used, a preliminary step of phosphorylation of free 5’ ends of the linearized 
plasmid must be performed. Re-circularization is achieved by incubating the mix 
with a ligase (Dominy and Andrews 2003). 
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Primers were designed according to the desired mutation and satisfying the 
following characteristics: possibly only one of the two primers contained the desired 
mutation; they annealed to adjacent and opposite strands of the plasmid; primers 
were between 25 and 45 bases length, with a melting temperature (Tm) of around 60 
°C (see appendix II). Primers longer than 45 bases were avoided because of the 
increase of the likelihood of secondary structure formation, which may affect the 
efficiency of the mutagenesis reaction. Tm was calculated as below 
€ 
Tm = 4°C⋅ (G +C) + 2°C⋅ (A +T)  
where G is the number of guanine present in the primer, C cytosine, A adenine and 
T thymine. Primers optimally should have a minimum GC content of 40% and 
should terminate in one or more C or G bases. 
In the genetic code, glutamate could be encoded by the triplet of nucleic bases gaa 
or gag, Aspartate by gac or gat and Lysine by aaa or aag. Primers were designed 
trying to minimase the mismatches: triplet gaa was mutated in aaa, gag and gac in 
aag (figure 6.17).  
 
5'-atggattacttcaccctctttggcttgcctgcccgctatcaactcgatacccaggcgctg-3' 
    M  D  Y  F  T  L  F  G  L  P  A  R  Y  Q  L  D  T  Q  A  L 
5'-agcctgcgttttcaggatctacaacgtcagtatcatcctgataaattcgccagcggaagc-3' 
    S  L  R  F  Q  D  L  Q  R  Q  Y  H  P  D  K  F  A  S  G  S 
5'-caggcggaacaactcgccgccgtacagcaatctgcaaccattaaccaggcctggcaaacg-3' 
    Q  A  E  Q  L  A  A  V  Q  Q  S  A  T  I  N  Q  A  W  Q  T 
5'-ctgcgtcatccgttaatgcgcgcggaatatttgctttctttgcacggctttgatctcgcc-3' 
    L  R  H  P  L  M  R  A  E  Y  L  L  S  L  H  G  F  D  L  A 
5'-agcgagcagcatactgtgcgcgacaccgcgttcctgatggaacagttggagctgcgcgaa-3' 
    S  E  Q  H  T  V  R  D  T  A  F  L  M  E  Q  L  E  L  R  E 
5'-gagctggacgagatcgaacaggcgaaagatgaagcgcggctggaaagctttatcaaacgt-3' 
    E  L  D  E  I  E  Q  A  K  D  E  A  R  L  E  S  F  I  K  R 
5'-gtgaaaaagatgtttgatacccgccatcagttgatggttgaacagttagacaacgagacg-3' 
    V  K  K  M  F  D  T  R  H  Q  L  M  V  E  Q  L  D  N  E  T 
5'-tgggacgcggcggcggataccgtgcgtaagctgcgttttctcgataaactgcgaagcagt-3' 
    W  D  A  A  A  D  T  V  R  K  L  R  F  L  D  K  L  R  S  S 
5'-gccgaacaactcgaagaaaaactgctcgatttttaataa-3' 
    A  E  Q  L  E  E  K  L  L  D  F  -  - 
Figure 6.17 DNA sequence coding for HscB. Positions of the point mutations are evidenced in 
colour. 
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The PCR program was set with the following parameters. For the annealing step a 
temperature gradient of 10 °C was set in the PCR machine grid. This allowed 
performing reactions at different temperature at the same time. 
 
Table 6.5 PCR program used for the site-directed mutagenesis of HscB to produce HscB_E100K, 
HscB_E111K/E115K, HscB_E134K/D137K and HscB_E165K/E166K mutants. 
 
The PCR products were purified, the plasmids purity was checked on an agar gel 
and their sequence checked. Proteins were then expressed and purified following 
the same protocol as the wild-type HscB. I probed the fold of mutants by circular 
dichroism. CD spectra were recordeded in the range between 195 and 260nm and 
compared with the wild-type curve. 
 
Figure 6.18 CD spectra of HscB mutants: HscB_E100K (green), HscB_E111KE115K (magenta), 
HscB_E134K/D137K (yellow), HscB_E165K/E166K (cyan) and HscB wt (black) with a protein 
concentration of 10 µM in 20 mM Tris-HCl pH 8, 150 mM NaCl and 2 mM DTT, at room temperature, in 
cuvettes of 1 cm path length with 0.1 nm of resolution, a band width of 2 nm and a scan speed of 200 
nm/min and accumulated 30 times. The baseline correction was obtained by subtraction of the buffer 
spectrum. 
Preheat lid 105°C



























































	   130	  
The spectra of HscB mutants are all superposable on that of the wild-type proving 
that they retain the fold and do not present alterations, as it was expected since the 
mutations affect exposed residues (figure 6.18).  
The ability of these mutants to bind IscS was tested by NMR and compared with 
that of HscB wild-type. If the spectrum of the mutant is not affected by addition of 
IscS the binding has been suppressed confirming that residues mutated belong to 
the surface of interaction.  
 
 
Figure 6.19 (A) HSQC-NMR spectra of HscB mutants. 15N-labelled HscB_E100K 100 µM (black) 
and 15N-labelled HscB_E100K in the presence of the IscS (1:1) (green) at 298 K in 20 mM Tris-HCl pH 
8, 150 mM NaCl and 2 mM DTT. 
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Figure 6.19 (B) HSQC-NMR spectra of HscB mutants. 15N-labelled HscB_E111K/E115K 100 µM 
(black) and 15N-labelled HscB_E111K/E115K in the presence of the IscS (1:1) (magenta) at 298 K in 
20 mM Tris-HCl pH 8, 150 mM NaCl and 2 mM DTT. 
 
Figure 6.19 (C) HSQC-NMR spectra of HscB mutants. 15N-labelled HscB_E134K/D137K 100 µM 
(black) and 15N-labelled HscB_E134K/D137K in the presence of the IscS (1:1) (yellow) at 298 K in 20 
mM Tris-HCl pH 8, 150 mM NaCl and 2 mM DTT. 
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Figure 6.19 (D) HSQC-NMR spectra of HscB mutants. 15N-labelled HscB_E165K/E166K 100 µM 
(black) and 15N-labelled HscB_E165K/E166K in the presence of the IscS (1:1) (cyan) at 298 K in 20 
mM Tris-HCl pH 8, 150 mM NaCl and 2 mM DTT. 
 
With the only exception of HscB_E134K/D137K (figure 6.19 (C)), addition of IscS to 
the HscB mutants had effects visibly milder than the wild-type, with HscB_E100K 
showing the smaller effect (figure 6.19 (A, B, D).  
To conclude the study, I performed the enzymatic kinetic assay: I checked the effect 
of the mutants on the ability of the system made by desulfurase IscS and the 
scaffold IscU to compose the Fe-S cluster. Kinetics were carried out in the presence 
of the individual mutants, with aconitase2 as protein reporter and under the same 
conditions used above (see chapter 4).  
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Figure 6.20 Effect of HscB mutants on the kinetics of Fe-S cluster formation on Aco2 (50 µM) in 
the presence of 1 µM IscS, 8µM IscU and 10 µM HscB wt (red) or HscB_E100K (green) or 
HscB_E111KE115K (magenta) or HscB_E134K/D137K (yellow) or HscB_E165K/E166K (cyan) in 20 
mM Tris-HCl pH 8, 150 mM NaCl, 3 mM DTT, 250 µM Cys and 25 µM Fe2+. The control in the absence 
of HscB is reported in black.  
 
Accordingly with what was expected, all the HscB mutants led to effects comparable 
with the control assay in the absence of HscB. I observed inhibition only for the 
mutant HscB_E134K/D137K (figure 6.20). 
Overall, these results confirm the interaction between IscS and HscB and validate 
the binding interface. It can thus be concluded that HscB binds weakly but specificly 
to IscS and prevalently through polar contacts involving its C-terminus domain. 
 
6.5 Discussion 
HscB presents a L-shaped structure with two arms, one spanning the C-terminus, 
the other the J-domain, with different length. NMR HSQC spectra and then cross 
saturation experiments confirmed that HscB is able to bind IscS and revealed that 
the binding involves a side of the long stem and causes a conformational 
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Some residues of IscS, belonging to specific and strategic positions for its function 
or for the interaction with other proteins, were mutated by previously researcher in 
Pastore’s lab (Prischi, Konarev et al. 2010, Yan, Konarev et al. 2013). Investigating 
their effect on the HSQC spectrum of HscB, I identified some of the sites of IscS 
implicated in the binding. The surface of interaction seems to involve the cavity of 
IscS in the interface between the two protomers and the active site. This surface is 
already involved in the interaction with other components of the Isc machine, which 
binds with similar weak affinity, as frataxin CyaY and ferredoxin (Prischi, Konarev et 
al. 2010, Yan, Konarev et al. 2013). For this reason I tested the ability of CyaY and 
FdX to abolish binding of of HscB to IscS. I observed that frataxin replaces HscB to 
form a more stable complex with IscS. On the other side a higher amount of FdX 
was needed. As the same surface of interaction is involved in the binding with 
different proteins, it is interesting to suppose the requirement of a tight regulation 
which establishes which protein is bound at a specific time.  
Interestingly the proposed binding sites on HscB for IscU involve residues that are 
close to the region that binds to IscS (Fuzery, Tonelli et al. 2008, Kim, Fuzery et al. 
2009, Fuzery, Oh et al. 2011). According to what I observed experimentally, 
contemporaneus binding is still possible and they could form a complex formed by 
HscB, IscU and IscS, a hypothesis not previously considered. The Isc machinery is 
supposed to work forming different complexes at time made by proteins with a 
specific function relevant for each specific step of the Fe-S cluster synthesis. On the 
contrary, these last results opened to the possibility of a different mechanism in 
which IscS acts as template of a multicomplex system.  
Finally, NMR-HSQC experiments and kinetic assays with specificly designed acid-
to-base mutants of HscB confirmed that the two proteins interact through an 
electrostatic binding, as was suggested by the HADDOCK models. 
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6.6 Methods 
15N-labelled and 2H, 15N-labelled protein expression 
15N and 2H,15N-labelled proteins were prepared for NMR HSQC and Cross 
saturation experiments. Plasmids were inserted into BL21(DE3) E. coli cells by 
transformation and these were grown in minimal medium composed by M9 salts 
with 3 g/L of D-glucose and using 1 g/L of (15NH4)2SO4 as the sole source of 
nitrogen. To obtain the 2H-labelling, minimal medium contained D2O instead of 
water. Proteins were then expressed and purified as previously described. 
 
NMR spectroscopy 
NMR spectra were acquired on Bruker AVANCE spectrometers operating at 600, 
700 and 800 MHz proton frequencies. Typically, measurements were carried out at 
298K in 20 mM Tris-HCl pH 8, 150 mM NaCl and 2 mM DTT using a 0.1 mM 
uniformly 15N-enriched HscB free and titrated with 0.1 and 0.2 mM of IscS. Water 
suppression was achieved by using WATERGATE (Piotto, Saudek et al. 1992). 
Spectra were processed by using the NMRPipe program (Delaglio, Grzesiek et al. 
1995) and analyzed by Ccpnmr (Vranken, Boucher et al. 2005). Spectral 
assignment of HscB was based was based on the BMRB deposition (entry ID 
15541). 
 
Cross Saturation transfer NMR experiment 
Cross saturation experiments were performed on a Bruker AVANCE III 
spectrometer at 950 MHz at 298 K, using TROSY detection on a sample of 0.100 
mM 2H,15N-labelled HscB alone or in the presence of 0.100 mM IscS. Saturation of 
aliphatic resonances was achieved using a train of hyperbolic secant pulses of 
50ms duration, giving a saturation bandwidth of +/-200 Hz, centered at 0.5 ppm. The 
overall duration of the saturation was 1s. The intensity of the amide peaks in the 
experiment in which the aliphatic hydrogen were saturated (on-resonance 
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experiment) was compared with the intensity of the amide peaks in the control off-
resonance experiment. 
 
HADDOCK Model building 
Docking of the complex between HscB and dimer IscS was computed using the 
HADDOCK webserver interface service (http://haddock.chem.uu.nl) (de Vries 2010) 
using 1FPO and 1P3W as starting structures respectively. For IscS active 
ambiguous interaction restraints (AIRs) were defined as R220, R223, R225, R39, 
and W45, for the first protomer and K101 and K105 for the second promoter; 
passive AIRs were defined automatically. For HscB, active AIRs were defined as 
residues L22, Q49, Q56, A80, Q95, D110, E111, K119, S160, Q163, E166, D170 
and passive AIRs were defined automatically by HADDOCK. 
 
Site-directed mutagenesis and plasmids amplification 
HscB mutants HscB_E100K, HscB_E111K/E115K, HscB_E134K/D137K and 
HscB_E165K/E166K were prepared by site-directed mutagenesis of the construct 
pET-24 HscB (already available in Pastore’s lab) by amplification with KAPA HiFi 
PCR Kit and using primers ordered on Integrated DNA Techonology. PCR mixture 
was prepared with 1 µL of dNTP 2 mM, primers 0.25 µM, pET-24 template plasmid 
0.2 µM and KAPA HiFi polymerase. After a pre-heat of the lid at 105 °C, the PCR 
program started reaching 98 °C for 2 min. The grid maintained a temperature of 98 
°C for 15 s, reached the different annealing temperature (55.8, 57.9, 59.6, 61.6 or 
63.6 °C) for 30 s and 72 °C for 4.5 s. The reaction ended with 5 min at 72 °C. The 
PCR product was incubated for 30 min at 37 °C with 1 µL of DpnI and purified with a 
Zymo Research PCR cleanup Kit. The plasmid purity was checked on an agar gel. 
After incubation at 37 °C for 30 min with 1 µL of T4 PNK, 1 µL of Quick ligase was 
added at room temperature for 10 min. Plasmid sequences was checked through 
the GATC service with T7 primers.  
HscB mutants were expressed and purified from E. coli strain BL21(DE3) as 
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previously described. To prepare 15N-labelled proteins for NMR HSQC experiments, 
BL21(DE3) E. coli cells were grown in minimal medium composed by M9 salts with 
3 g/L of D-glucose and using 1 g/L using (15NH4)2SO4 as the sole source of nitrogen. 
 
CD spectrum 
Far-UV CD spectra were recorded on a Jasco J-815 CD Spectrometer. 
Measurements were repeated at least twice on independent protein preparations to 
ensure reproducibility of the results. Samples were prepared using a protein 
concentration of 10 µM in 20 mM Tris-HCl pH 8, 150 mM NaCl and 2 mMDTT. 
Measurements were carried out at room temperature in fused silica cuvettes of 1 cm 
path length (Hellma). Typically CD spectra were recorded between 195 and 260 nm, 
accumulated 30 times, with 0.1 nm of resolution, a band width of 2 nm and a scan 
speed of 200 nm/min. A nitrogen flow assured anaerobic conditions and a baseline 
correction was obtained by subtraction of the appropriate buffer spectrum. 
 
Reconstitution experiments 
Enzymatic cluster formation was achieved under strict anaerobic conditions in a 
Belle chamber kept under nitrogen atmosphere. The reaction was followed by 
absorbance spectroscopy using a Cary 50 Bio Spectrophotometer (Varian). 
Absorbance variations at 406 nm were measured as a function of time. A solution of 
50 µM of Aco2 was incubated in sealed cuvettes typically using 3 mM DTT, 8µM 
IscU, 3µM HscB (wild type or mutant), 1 µM IscS and 25 µM Fe(NH4)2(SO4)2 for 30 
minutes in 20 mM Tris-HCl pH 8 and 150 mM NaCl. The reaction was initiated by 
adding 250 µM of the substrate L-cysteine. Each experiment was repeated at least 3 
times on different batches of proteins. 
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CONCLUSION 
Friedreich’s ataxia is a neurodegenerative disease caused by the deficiency of 
frataxin, an iron binding protein present in mitochondrial matrix (Pandolfo and 
Pastore 2009). Patients affected by this pathology show abnormalities in the iron 
metabolism and damage caused by oxidative stress (Pandolfo and Pastore 2009). 
Thus, although frataxin function is still unclear it seems to be involved in Fe-S 
cluster biogenesis (Pandolfo and Pastore 2009). To understand the functioning of 
the machinery of Fe-S cluster formation became thus of extreme importance in 
order to get new insights about the mechanism of neurodegenerative diseases such 
as Friedreich ataxia. Since frataxin is extremely conserved between species 
(Gibson, Koonin et al. 1996), bacterial cells are a simpler system suitable to 
characterize protein functions. In bacteria Fe-S clusters are synthesised by a 
relatively complex machinery that involves several proteins expressed by the same 
operon isc (Tokumoto and Takahashi 2001). 
For the first time I investigated the Fe-S cluster formation in the presence of the 
chaperones HscA, HscB and ATP in addition to desulfurase IscS and scaffold 
protein IscU. For each component I found the best concentration for which the effect 
is maximum. Usually chaperones are intended as “helpers of folding” and so are 
expected to activate the enzyme activity (Chandramouli and Johnson 2006), 
conversely, I observed that HscB, alone and in the co-presence of HscA, causes a 
decrease in the rate of cluster formation as it was already showed by Iametti et al. 
(Iametti, Barbiroli et al. 2015). The inhibitory effect of HscB is independent from the 
Fe-S cluster acceptor used. Iametti et al. affirmed its independency also from the 
source of sulfur and explained the effect with the interaction between IscU and the 
chaperones (Iametti, Barbiroli et al. 2015). However, I demonstrated that HscB 
slows down also cysteine desulfuration. 
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I demonstrated the inhibition of the IscS activity proving a previously unidentified 
interaction between HscB and the desulfurase. They bind with an affinity constant 
KD of around 10 µM comparable with KD values established for interactions of others 
Isc proteins (∼20 µM for IscS-CyaY (Prischi, Konarev et al. 2010); ∼13 µM for HscB-
IscU (Hoff, Silberg et al. 2000)) . 
The HscB surface of interaction maps into a side of the C-terminus of its L-shaped 
structure. On the other hand, IscS binds the co-chaperone through the cleft in the 
interface between the two protomers and the active site. This is the site where also 
YfhJ, ferredoxin and CyaY, the bacterial otholog of frataxin, bind (Pastore, Adinolfi 
et al. 2006, Prischi, Konarev et al. 2010, Yan, Konarev et al. 2013). It was previously 
demonstrated by molecular dynamics that the binding of CyaY in this site can 
restrict the motions of the catalytic loop which is thought to transfer persulfide, 
bound to Cys238, to the nearby IscU (di Maio, Chandramouli et al. 2017). Similarly, 
the interaction with HscB could interfere with the loop movement by steric hindrance 
explaining the inhibitory effect on Fe-S cluster formation. 
My studies have suggested a competition between HscB and CyaY and between 
HscB and ferredoxin for the same binding surface of IscS. This competition could 
suggest a link between these proteins with a functional significance. It is intriguing 
how multiple interactions of IscS with very different proteins involve the same 
surface of binding and suggest the requirement of a tight regulation on which 
specific protein is bound at the different time points. A possible way to explain my 
findings is to remember that IscS is a dimer. This means that, in the presence of 
suitable different effectors, different interactions may in principle be possible on the 
two IscS protomers leading to a complex but efficient regulation according to an 
allosteric mechanism (figure 7). 
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Figure 7 Scheme to illustrate the possible regulation of the IscS interactions. Different effectors 
may signal which components are bound to IscS at any time point keeping in mind that IscS is a dimer. 
The possibility of occupying two independent binding sites also makes room to the possibility that 
allosteric mechanisms may operate. 
 
At the same time, the possibility of HscB to bind concomitantly IscU and IscS was 
probed and suggests the possibility that IscS acts as the template and mediates the 
interaction of the chaperones with its preferential partner IscU. An IscS-mediated 
interaction with IscU was also observed for the bacterial frataxin CyaY which does 
not interact directly with IscU at variance with the longer eukaryotic orthologue 
(Layer, Ollagnier-de Choudens et al. 2006, Adinolfi, Iannuzzi et al. 2009). 
My unexpected results may change completely the perspective of the events 
involved in the Isc machine: the whole scene of action for Fe-S cluster formation 
seems now to gravitate around IscS rather than involving two different machines, 
one on IscS and the other on the two chaperones. It also proposes a potentially 
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different role of the two chaperones: they may not be just passive players able to 
“help” folding but more active components of the cellular machine. A similar view 
was also put forward in a recent comprehensive review in which it is proposed that 
chaperones are unfoldases (Finka, Mattoo et al. 2016). This hypothesis could 
represent a further explaination of the inhibitory effect of HscB and HscB/HscA on 
cluster formation and on desulfuration. It would also explain evidence suggesting 
that HscB binds preferentially the structured state of IscU (Kim, Tonelli et al. 2012). 
However, the exact role of HscB on IscS is still open. 
While much more needs to be done to completely unveil the structural and 
functional understanding of the Fe-S cluster biogenesis, my studies add up a new 
tessera to the comprehension of the isc machine and its regulation and open new 
avenues to the perception of the role of chaperones. 
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APPENDIX I – NMR ANALYSIS 
I.I Chemical shift perturbation and spectrum broadening 
In principle, a good analysis of variation of a protein HSQC spectrum after the 
binding with a ligand, allows the determination of the surface of interaction. I tried to 
identify the region of HscB responsible for the interaction with IscS with a molar ratio 
of 1:1. Unfortunately the binding causes the formation of a complex of around 130 
kDa that increases the correlation time with a significant broadening in the 
spectrum. This made the analysis hard and the precise identification of the residues 
involved difficult. 
First, for each resonance, I plotted the chemical shift perturbation upon IscS addition 




2 + 0.15δN2 )  and I selected those with 
€ 
Δδ ≥ 0.018ppm  (L22, H63, Q95, R99, E104, E106, E111, I118, K119, M124, L157, 
A161 and D170) (figure I.I). 
 
 
Figure I.I Chemical shift perturbation in the HSQC spectrum of 100 µM HscB after the addition of 
IscS (1:1) at 298K in 20 mM Tris-HCl pH 8, 150 mM NaCl and 2 mM DTT. 
 
To estimate the region that is more affected by the broadening, for each peak I 
measured the variation in height and in volume compared with the values in the free 
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protein spectrum. I identified residues for which both values exceed 90% of variation 
(Q14, L20, E104, E106, Q107, D110, E111, F117, I118, L131, Q135, D155, L157, 




Figure I.II Peaks broadening determination. Variations of height and volume of peaks in the HSQC 
spectrum of 100 µM HscB after the addition of IscS (1:1) at 298K in 20 mM Tris-HCl pH 8, 150 mM 
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I.II Analysis of cross saturation experiment 
To perform the cross saturation experiment, HscB was expressed and purified as 
uniformly labelled with 2H and 15N. Levels of deuteration of around 90% were 
obtained and, since some protons were still present in the protein side chains, HscB 
free spectrum was not completely aneffected by cross saturation sequence. I then 
recorded the spectrum after the addition of IscS (1:1).  
For both the samples (HscB and HscB:IscS mixture), I plotted the difference 
between the TROSY spectrum recorded in the experiment with the aliphatic 
hydrogen saturated and the spectrum in which the aliphatic radio frequence was off. 
The spectra obtained presented high levels of noise and weak signals. In order to 
avoid artifacts due to the not perfect deuteration of HscB, height and volume values 
of peaks in the free protein sample were subtracted from the values in the mixture. I 
finally identified residues for which both values of heigh and volume overseeded the 
average value of variation plus one standard deviation (L22, Q49, Q56, 
A80, Q95, D110, E111, K119, S160, Q163, E166, D170, and F171) (figure I.III). 
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Figure I.III Determination of residues affected by cross saturation. Variations of height and volume 
in the TROSY spectrum of 100 µM HscB after the addition of IscS (1:1) at 298 K in 20 mM Tris-HCl pH 
8, 150 mM NaCl and 2 mM DTT. Saturation of aliphatic resonances was achieved with a pulses 
centered at 0.5 ppm. 
	   146	  
APPENDIX II – PRIMERS DESIGN 
Below are reported the schemes of the primers designed and ordered from 
Integrated DNA Techonology (IDT) for the HscB site-directed mutagenesis. 
Mutatated residues are indicated. Forward primers, in the 5’-3’ direction, are 
reported in bold. Reverse primers, in the 3’-5’ direction, are underlined. They were 





HscB E100K sequence 
5'-atggattacttcaccctctttggcttgcctgcccgctatcaactcgatacccaggcgctg-3' 
    M  D  Y  F  T  L  F  G  L  P  A  R  Y  Q  L  D  T  Q  A  L  
5'-agcctgcgttttcaggatctacaacgtcagtatcatcctgataaattcgccagcggaagc-3' 
    S  L  R  F  Q  D  L  Q  R  Q  Y  H  P  D  K  F  A  S  G  S  
5'-caggcggaacaactcgccgccgtacagcaatctgcaaccattaaccaggcctggcaaacg-3' 
    Q  A  E  Q  L  A  A  V  Q  Q  S  A  T  I  N  Q  A  W  Q  T  
5'-ctgcgtcatccgttaatgcgcgcggaatatttgctttctttgcacggctttgatctcgcc-3' 
    L  R  H  P  L  M  R  A  E  Y  L  L  S  L  H  G  F  D  L  A  
5'-agcgagcagcatactgtgcgcgacaccgcgttcctgatggaacagttggagctgcgcAaa-3' 
    S  E  Q  H  T  V  R  D  T  A  F  L  M  E  Q  L  E  L  R  K  
5'-gagctggacgagatcgaacaggcgaaagatgaagcgcggctggaaagctttatcaaacgt-3' 
    E  L  D  E  I  E  Q  A  K  D  E  A  R  L  E  S  F  I  K  R  
5'-gtgaaaaagatgtttgatacccgccatcagttgatggttgaacagttagacaacgagacg-3' 
    V  K  K  M  F  D  T  R  H  Q  L  M  V  E  Q  L  D  N  E  T  
5'-tgggacgcggcggcggataccgtgcgtaagctgcgttttctcgataaactgcgaagcagt-3' 
    W  D  A  A  A  D  T  V  R  K  L  R  F  L  D  K  L  R  S  S  
5'-gccgaacaactcgaagaaaaactgctcgatttttaataa-3' 
    A  E  Q  L  E  E  K  L  L  D  F  -  -   
Primers sequence 
E100K_forward  5'-gagctgcgcAaagagctgg-3' 
%GC: 58 and Tm: 66°C 
 
E100K_reverse  5'-caactgttccatcaggaacgc-3' 
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HscB E111,115K sequence 
5'-atggattacttcaccctctttggcttgcctgcccgctatcaactcgatacccaggcgctg-3' 
    M  D  Y  F  T  L  F  G  L  P  A  R  Y  Q  L  D  T  Q  A  L  
5'-agcctgcgttttcaggatctacaacgtcagtatcatcctgataaattcgccagcggaagc-3' 
    S  L  R  F  Q  D  L  Q  R  Q  Y  H  P  D  K  F  A  S  G  S  
5'-caggcggaacaactcgccgccgtacagcaatctgcaaccattaaccaggcctggcaaacg-3' 
    Q  A  E  Q  L  A  A  V  Q  Q  S  A  T  I  N  Q  A  W  Q  T  
5'-ctgcgtcatccgttaatgcgcgcggaatatttgctttctttgcacggctttgatctcgcc-3' 
    L  R  H  P  L  M  R  A  E  Y  L  L  S  L  H  G  F  D  L  A  
5'-agcgagcagcatactgtgcgcgacaccgcgttcctgatggaacagttggagctgcgcgaa-3' 
    S  E  Q  H  T  V  R  D  T  A  F  L  M  E  Q  L  E  L  R  E  
5'-gagctggacgagatcgaacaggcgaaagatAaagcgcggctgAaaagctttatcaaacgt-3' 
    E  L  D  E  I  E  Q  A  K  D  K  A  R  L  K  S  F  I  K  R  
5'-gtgaaaaagatgtttgatacccgccatcagttgatggttgaacagttagacaacgagacg-3' 
    V  K  K  M  F  D  T  R  H  Q  L  M  V  E  Q  L  D  N  E  T  
5'-tgggacgcggcggcggataccgtgcgtaagctgcgttttctcgataaactgcgaagcagt-3' 
    W  D  A  A  A  D  T  V  R  K  L  R  F  L  D  K  L  R  S  S  
5'-gccgaacaactcgaagaaaaactgctcgatttttaataa-3' 
    A  E  Q  L  E  E  K  L  L  D  F  -  - 
Primers sequence 
E111,115K_forward  5'-cggctgAaaagctttatcaaac-3' 
%GC: 41 and Tm: 61°C 
 
E111,115K_reverse  5'-cgcttTatctttcgcctgt-3' 
%GC: 47 and Tm: 61°C 
 
 
HscB E134K, D137K sequence 
 
5'-atggattacttcaccctctttggcttgcctgcccgctatcaactcgatacccaggcgctg-3' 
    M  D  Y  F  T  L  F  G  L  P  A  R  Y  Q  L  D  T  Q  A  L  
5'-agcctgcgttttcaggatctacaacgtcagtatcatcctgataaattcgccagcggaagc-3' 
    S  L  R  F  Q  D  L  Q  R  Q  Y  H  P  D  K  F  A  S  G  S  
5'-caggcggaacaactcgccgccgtacagcaatctgcaaccattaaccaggcctggcaaacg-3' 
    Q  A  E  Q  L  A  A  V  Q  Q  S  A  T  I  N  Q  A  W  Q  T  
5'-ctgcgtcatccgttaatgcgcgcggaatatttgctttctttgcacggctttgatctcgcc-3' 
    L  R  H  P  L  M  R  A  E  Y  L  L  S  L  H  G  F  D  L  A  
5'-agcgagcagcatactgtgcgcgacaccgcgttcctgatggaacagttggagctgcgcgaa-3' 
    S  E  Q  H  T  V  R  D  T  A  F  L  M  E  Q  L  E  L  R  E  
5'-gagctggacgagatcgaacaggcgaaagatgaagcgcggctggaaagctttatcaaacgt-3' 
    E  L  D  E  I  E  Q  A  K  D  E  A  R  L  E  S  F  I  K  R  
5'-gtgaaaaagatgtttgatacccgccatcagttgatggttAaacagttaAaGaacgagacg-3' 
    V  K  K  M  F  D  T  R  H  Q  L  M  V  K  Q  L  K  N  E  T  
5'-tgggacgcggcggcggataccgtgcgtaagctgcgttttctcgataaactgcgaagcagt-3' 
    W  D  A  A  A  D  T  V  R  K  L  R  F  L  D  K  L  R  S  S  
5'-gccgaacaactcgaagaaaaactgctcgatttttaataa-3' 
    A  E  Q  L  E  E  K  L  L  D  F  -  -   
Primers sequence: 
E134K, D137K_forward  5'-ttaAaGaacgagacgtgggac-3' 
%GC: 48 and Tm: 61°C 
 
E134K, D137K_reverse  5'-ctgttTaaccatcaactgatgg-3' 
%GC: 41 and Tm: 60°C 
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HscB E165,166K sequence 
5'-atggattacttcaccctctttggcttgcctgcccgctatcaactcgatacccaggcgctg-3' 
    M  D  Y  F  T  L  F  G  L  P  A  R  Y  Q  L  D  T  Q  A  L  
5'-agcctgcgttttcaggatctacaacgtcagtatcatcctgataaattcgccagcggaagc-3' 
    S  L  R  F  Q  D  L  Q  R  Q  Y  H  P  D  K  F  A  S  G  S  
5'-caggcggaacaactcgccgccgtacagcaatctgcaaccattaaccaggcctggcaaacg-3' 
    Q  A  E  Q  L  A  A  V  Q  Q  S  A  T  I  N  Q  A  W  Q  T  
5'-ctgcgtcatccgttaatgcgcgcggaatatttgctttctttgcacggctttgatctcgcc-3' 
    L  R  H  P  L  M  R  A  E  Y  L  L  S  L  H  G  F  D  L  A  
5'-agcgagcagcatactgtgcgcgacaccgcgttcctgatggaacagttggagctgcgcgaa-3' 
    S  E  Q  H  T  V  R  D  T  A  F  L  M  E  Q  L  E  L  R  E  
5'-gagctggacgagatcgaacaggcgaaagatgaagcgcggctggaaagctttatcaaacgt-3' 
    E  L  D  E  I  E  Q  A  K  D  E  A  R  L  E  S  F  I  K  R  
5'-gtgaaaaagatgtttgatacccgccatcagttgatggttgaacagttagacaacgagacg-3' 
    V  K  K  M  F  D  T  R  H  Q  L  M  V  E  Q  L  D  N  E  T  
5'-tgggacgcggcggcggataccgtgcgtaagctgcgttttctcgataaactgcgaagcagt-3' 
    W  D  A  A  A  D  T  V  R  K  L  R  F  L  D  K  L  R  S  S  
5'-gccgaacaactcAaaAaaaaactgctcgatttttaataagcg-3' 
    A  E  Q  L  K  K  K  L  L  D  F  -  -   
Primers sequence 
E165,166K_forward  5'-cgaacaactcAaaAaaaaactgctcg-3' 
%GC: 42 and Tm: 65°C 
 
E165,166K_reverse  5'-gcactgcttcgcagtttatcg-3' 
%GC: 52 and Tm: 66°C 
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APPENDIX III – ISC PROTEINS STRUCTURAL 
REVIEW 
Three-dimensional structures of Isc proteins and their complexes provided important 
insight into the process of Fe-S cluster biosynthesis and transfer. The scheme 
below summarizes the relevant information about all the Isc protein structures 
deposited in PDB. 
 
 
Table IV Proteins involved in iron-sulfur cluster assembly and relevant structural information (Kim, 
Bothe et al. 2015). 
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APPENDIX IV - PUBLICATIONS 
Papers published during my PhD course of which I am one of the author: 
 
 
Puglisi R., Yan R., Adinolfi S. and Pastore A., (2016). A new tessera into the 
interactome of the isc operon: A novel interaction between HscB and IscS. 
Front. Mol. Biosci. 3:48.  
 
Faggianelli N., Puglisi R., Veneziano L., Romano S., Frontali M., Vannocci T., 
Fortuni S., Testi R. and Pastore A. (2015). Analyzing the Effects of a G137V 
Mutation in the FXN Gene. Frontiers in Molecular Neuroscience, 8, 66.  
 
Iannuzzi C., Adrover M., Puglisi R., Yan R., Temussi P. A., & Pastore A. (2014). 
The role of zinc in the stability of the marginally stable IscU scaffold protein. 
Protein Science : A Publication of the Protein Society, 23(9), 1208–1219.  
 
Sanfelice D., Puglisi R., Martin S. R., Di Bari L., Pastore A., & Temussi P. A. 
(2014). Yeast Frataxin Is Stabilized by Low Salt Concentrations: Cold 
Denaturation Disentangles Ionic Strength Effects from Specific Interactions. 
PLoS ONE, 9(5), e95801. 
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